FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Sales, HF
   Cerqueira, C
   Vaz, D
   Medeiros-Rios, D
   Armani-Franceschi, G
   Lucena, PH
   Sternberg, C
   Nobrega, AC
   Luz, C
   Fonseca, D
   Carvalho, AL
   Monteiro, L
   Siqueira, IC
   Bandeira, ID
   Lucena, R
AF Sales, Henrique F.
   Cerqueira, Caroline
   Vaz, Daniel
   Medeiros-Rios, Debora
   Armani-Franceschi, Giulia
   Lucena, Pedro H.
   Sternberg, Carla
   Nobrega, Ana C.
   Luz, Cleber
   Fonseca, Danilo
   Carvalho, Alessandra L.
   Monteiro, Larissa
   Siqueira, Isadora C.
   Bandeira, Igor D.
   Lucena, Rita
TI The impact of botulinum toxin type A in the treatment of drooling in
   children with cerebral palsy secondary to Congenital Zika Syndrome: an
   observational study
SO NEUROLOGICAL RESEARCH
LA English
DT Article; Early Access
DE Cerebral palsy; Congenital Zika Syndrome; drooling; botulinum toxin type
   A; Doppler ultrasonography
ID SIALORRHEA; INJECTIONS; BRAZIL
AB Objective The main aim of this study was to determine the impact of botulinum toxin A (BTX-A) on severity and frequency of drooling in children with Cerebral Palsy (CP) secondary to Congenital Zika Syndrome (CZS). Methods This is a prospective longitudinal observational study including 23 children who received bilateral injections of BTX in the parotid and submandibular glands. The Thomas-Stonell & Greenberg Drooling Severity and Frequency Scale was applied by a multidisciplinary team including Speech, Language and Hearing professionals. The Global Impression of Improvement (GII) Scale was also applied to assess parents' subjective perceptions of therapeutic response. Swallowing was assessed using Doppler ultrasonography. Univariate logistic regression was used to analyse differences between responders and non-responders. Results Participant age varied from 27 to 38 months (mean 31.78, SD = 2.61) all presented with Gross Motor Function Classification System (GMFCS) V. Drooling Severity and Frequency Scale scores ranged from 7 to 9 points (median = 9) prior to BTX administration and from 4 to 6 (median = 6) after. Pre- and post-treatment reduction in drooling severity occurred (Z = -3.746; p < 0.001). No cases of drooling worsening were reported. Only two subjects presented adverse effects attributed to BTX administration. Correlation was only confirmed with GII. Discussion This article presents the safe and positive impact of BTX-A administration guided by anatomical references described in the literature, even on children with microcephaly. Further studies are needed to facilitate the use of Doppler ultrasonography as a tool to characterize changes in sensory processing and motor response following intraoral input in children with CP.
C1 [Sales, Henrique F.; Armani-Franceschi, Giulia] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Cerqueira, Caroline; Vaz, Daniel] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
   [Medeiros-Rios, Debora; Carvalho, Alessandra L.; Bandeira, Igor D.] Univ Fed Bahia, Fac Med Bahia, Programa Posgrad Med & Saude, Salvador, BA, Brazil.
   [Lucena, Pedro H.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Sternberg, Carla; Nobrega, Ana C.; Luz, Cleber; Fonseca, Danilo] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Monteiro, Larissa] Univ Fed Bahia, Fac Med Bahia, Dept Pediat, Salvador, BA, Brazil.
   [Siqueira, Isadora C.] Fundacao Oswaldo Cruz, Inst Goncalo Muniz, Salvador, BA, Brazil.
   [Bandeira, Igor D.] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Psiquiatria, Lab Neuropsicofarmacol, Salvador, BA, Brazil.
   [Lucena, Rita] Univ Fed Bahia, Fac Med Bahia, Dept Neurociencias & Saude Mental, Salvador, BA, Brazil.
RP Lucena, R (corresponding author), Univ Fed Bahia, BR-40110100 Salvador, BA, Brazil.
EM rcslucena@yahoo.com.br
RI Bandeira, Igor Dorea/J-8835-2015; Lucena, Rita/L-9842-2013; Nobrega, Ana
   Caline/ABC-5608-2020; de Siqueira, Isadora Cristina/R-9953-2016
OI Bandeira, Igor Dorea/0000-0002-6714-2658; Lucena,
   Rita/0000-0002-6190-9168; Nobrega, Ana Caline/0000-0002-6509-8702; de
   Siqueira, Isadora Cristina/0000-0002-2520-4099; Reis,
   AlessanRSS/0000-0001-8486-7469
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Alrefai AH, 2009, CLIN NEUROL NEUROSUR, V111, P79, DOI 10.1016/j.clineuro.2008.09.001
   Bandeira ID, 2018, INT J MED EDUC, V9, P170, DOI 10.5116/ijme.5b1b.b0a2
   Bandeira ID, 2017, MUSCLE NERVE, V56, pE10, DOI 10.1002/mus.25610
   Barreto TM, 2020, DEV MED CHILD NEUROL, V62, P163, DOI 10.1111/dmcn.14321
   Bothwell JE, 2002, PEDIATR NEUROL, V27, P18, DOI 10.1016/S0887-8994(02)00381-8
   Cagliari Cibele Fontoura, 2009, Braz. j. otorhinolaryngol., V75, P706, DOI 10.1590/S1808-86942009000500016
   Lagos HNC, 2013, INT ARCH OTORHINOLAR, V17, P383, DOI 10.1055/s-0033-1353369
   Dohar JE, 2019, INT J PEDIATR OTORHI, V116, P97, DOI 10.1016/j.ijporl.2018.10.035
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gonzalez-Luis MD, 2017, AM J PHYS MED REHAB, V96, P68, DOI 10.1097/PHM.0000000000000525
   Gubbay A, 2019, INT J PEDIATR OTORHI, V124, P124, DOI 10.1016/j.ijporl.2019.05.044
   Jackson CE, 2009, MUSCLE NERVE, V39, P137, DOI 10.1002/mus.21213
   Lim ECH, 2010, NAT REV NEUROL, V6, P624, DOI 10.1038/nrneurol.2010.149
   Ondo WG, 2004, NEUROLOGY, V62, P37, DOI 10.1212/01.WNL.0000101713.81253.4C
   Porte M, 2014, EUR J PAEDIATR NEURO, V18, P649, DOI 10.1016/j.ejpn.2014.05.007
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Rodwell K, 2012, DEV MED CHILD NEUROL, V54, P977, DOI 10.1111/j.1469-8749.2012.04370.x
   Scofano Dias BL, 2016, J PEDIAT RIO J, DOI [10.1016/j.jpedp.2016.06.002, DOI 10.1016/J.JPEDP.2016.06.002]
   Senner JE, 2004, DEV MED CHILD NEUROL, V46, P801, DOI 10.1017/S0012162204001409
   Thomas-Stonell N, 1988, Dysphagia, V3, P73, DOI 10.1007/BF02412423
   van Hulst K, 2017, DEV MED CHILD NEUROL, V59, P531, DOI 10.1111/dmcn.13333
NR 21
TC 0
Z9 0
U1 4
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0161-6412
EI 1743-1328
J9 NEUROL RES
JI Neurol. Res.
DI 10.1080/01616412.2020.1820698
EA SEP 2020
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA NN7AE
UT WOS:000568935800001
PM 32915712
DA 2020-12-09
ER

PT J
AU de Almeida, BL
   Silva, DV
   do Rosario, MS
   Goncalves, BSD
   Nunes, MG
   Ney, ALCM
   Silvany, C
   de Siqueira, IC
AF de Almeida, Breno Lima
   Silva, Daniel Vicente
   do Rosario, Mateus Santana
   Dias Goncalves, Bruno Simoes
   Nunes, Miria Guimaraes
   Chukr Mafra Ney, Andre Luis
   Silvany, Celia
   de Siqueira, Isadora Cristina
TI Biliary ascariasis and severe bacterial outcomes: Report of three cases
   from a paediatric hospital in Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Biliary ascariasis; Ascaris lumbricoides; Sepsis; Liver abscess
ID HELMINTH INFECTIONS; HEPATOBILIARY
AB Introduction: Biliary ascariasis, although uncommon, can lead to infectious complications and severe outcomes. This study reported three patients with biliary ascariasis and who were admitted to a paediatric hospital in Salvador, Brazil.
   Case reports: Case 1: A 1-year-old boy, with HIV, hospitalised with diarrhoea, fever, pain, and abdominal distension. He underwent an exploratory laparotomy, which showed peritonitis secondary to a perforation of the hepatic duct by ascaris. Case 2: A 3-year-old boy admitted with fever, abdominal pain and jaundice. Imaging examination was suggestive of ascaris in the intrahepatic biliary tract and a hepatic abscess. Case 3: A 7-year-old boy who was hospitalised with a history of abdominal colic, jaundice and fever, with a suggestive image of ascaris in the biliary tract and evolution to sepsis.
   Discussion: Three cases of biliary ascariasis were reported with severe infectious complications involving peritonitis, hepatic abscess and sepsis.
   Conclusion: In endemic regions, biliary ascariasis should be considered in cases with jaundice, abdominal pain and fever, due to its morbidity and risk of (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [de Almeida, Breno Lima; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Silva, Daniel Vicente; Dias Goncalves, Bruno Simoes; Nunes, Miria Guimaraes; Chukr Mafra Ney, Andre Luis; Silvany, Celia] Hosp Crianca Obras Sociais Irma Dulce, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Hosp Santa Izabel, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
CR Das AK, 2014, J GLOB INFECT DIS, V6, P65, DOI 10.4103/0974-777X.132042
   de Lima Corvino DF, 2019, ASCARIASIS
   Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261
   Khuroo MS, 2016, WORLD J GASTROENTERO, V22, P7507, DOI 10.3748/wjg.v22.i33.7507
   KHUROO MS, 1990, LANCET, V335, P1503, DOI 10.1016/0140-6736(90)93037-P
   KHUROO MS, 1987, GASTROENTEROLOGY, V93, P267, DOI 10.1016/0016-5085(87)91013-4
   Khuroo MS, 1996, GASTROENTEROL CLIN N, V25, P553, DOI 10.1016/S0889-8553(05)70263-6
   KHUROO MS, 1992, BRIT J SURG, V79, P1335, DOI 10.1002/bjs.1800791231
   Pereira Ricardo Mendes, 1995, Arquivos de Gastroenterologia, V32, P186
   Quintos Aranda C, 1990, Rev Gastroenterol Mex, V55, P61
   ROCHA MD, 1995, ABDOM IMAGING, V20, P317
   Sanai F M, 2007, Saudi J Gastroenterol, V13, P25, DOI 10.4103/1319-3767.30462
   Scholte RGC, 2013, GEOSPATIAL HEALTH, V8, P97, DOI 10.4081/gh.2013.58
   Uysal E, 2017, IRAN J PARASITOL, V12, P156
   WITCOMBE JB, 1978, PEDIATR RADIOL, V7, P124, DOI 10.1007/BF00975685
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2020
VL 95
BP 115
EP 117
DI 10.1016/j.ijid.2020.03.045
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA LY7VW
UT WOS:000540737100019
PM 32240824
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Duarte, AO
   Oliveira, JV
   Carvalho, TCX
   Pessoa, LD
   Magalhaes, C
   Lima, JGS
   Carvalho, DA
   dos Santos, DC
   Santos, CS
   Pessoa, R
   Souza, GB
   Calcagno, JI
   Santana, EM
   de Oliveira, AS
   Francisco, MVLD
   Costa, BGG
   Gomes, LN
   Romero, F
   Khouri, R
   Alcantara, LC
   Lima, FWD
   de Siqueira, IC
AF Duarte, Alan Oliveira
   Oliveira, Joao Vitor
   Xavier Carvalho, Tereza Cristina
   Pessoa, Lorena de Brito
   Magalhaes Filho, Claudio
   Souza Lima, Jessica Graziele
   Carvalho, Daniel Augusto
   dos Santos, Daiana Carlos
   Santos, Cleiton Silva
   Pessoa, Rosana
   Souza, Gloryane Bessa
   Calcagno, Juan Ignacio
   Santana, Edilene Mota
   de Oliveira, Aline Sousa
   de Oliveira Francisco, Marcos Vinicius Lima
   Gouvea Costa, Bernardo Gratival
   Gomes, Lillian Nunes
   Romero, Fernando
   Khouri, Ricardo
   Alcantara, Luiz Carlos, Jr.
   de Mendonca Lima, Fernanda Washington
   de Siqueira, Isadora Cristina
TI Maternal and congenital infections arising from Zika, dengue and
   Chikungunya arboviruses in Salvador, Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Chikungunya; congenital infection; microcephaly; seroprevalence; Zika
AB Background: Salvador was one of the Brazilian cities most affected during the 2015 Zika virus (ZIKV) outbreak.
   Methods: A cross-sectional study was performed with enrolment of parturients and their newborns.
   Results: Positive IgM antibodies for ZIKV, dengue (DENV) and Chikungunya (CHIKV) were present in 6.9, 11.9 and 22.8% of the parturients, and IgG antibodies were detected in 72.3, 92.3 and 38.6%, respectively. No cases of DENV congenital infection were identified. ZIKV and CHIKV congenital infections were observed in 16.5 and 13% of newborns, respectively.
   Conclusions: High exposure rates to the three arboviruses and the identification of newborns with ZIKV and CHIKV congenital infections reinforces the necessity of ZIKV and CHIKV prenatal and neonatal screening in endemic regions.
C1 [Duarte, Alan Oliveira; Santana, Edilene Mota; de Mendonca Lima, Fernanda Washington] Univ Fed Bahia, Fac Farm, Lab Imunol Doencas Infecciosas, BR-40170115 Salvador, BA, Brazil.
   [Oliveira, Joao Vitor; Pessoa, Lorena de Brito; Magalhaes Filho, Claudio; Souza Lima, Jessica Graziele; Carvalho, Daniel Augusto; dos Santos, Daiana Carlos; Santos, Cleiton Silva; de Oliveira, Aline Sousa; de Oliveira Francisco, Marcos Vinicius Lima; Gouvea Costa, Bernardo Gratival; Gomes, Lillian Nunes; Khouri, Ricardo; Alcantara, Luiz Carlos, Jr.; de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Xavier Carvalho, Tereza Cristina; Pessoa, Rosana; Souza, Gloryane Bessa; Calcagno, Juan Ignacio; Romero, Fernando] Maternidade Referencia Prof Jose Maria Magalhaes, BR-40320350 Salvador, BA, Brazil.
   [Khouri, Ricardo] Univ Fed Bahia, Fac Med, Dept Patol & Med Legal, BR-40110100 Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
FU National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [425380/2016]; WHO's HRP/TDR/PAHO Joint Small Grants Program for
   research on the ZIKV outbreak in the Americas [770084-0/2017];
   Foundation of Support to Research of the State of Bahia
   [19.573.201.5418]
FX This work was supported by the National Council for Scientific and
   Technological Development [425380/2016], WHO's HRP/TDR/PAHO Joint Small
   Grants Program for research on the ZIKV outbreak in the Americas
   [770084-0/2017] and Foundation of Support to Research of the State of
   Bahia [19.573.201.5418].
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 3
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2020
VL 114
IS 3
BP 222
EP 224
DI 10.1093/trstmh/trz098
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LS6DO
UT WOS:000536472500009
PM 32142153
DA 2020-12-09
ER

PT J
AU Dias, TT
   Tauro, LB
   Macedo, LEN
   Brito, LO
   Ribeiro, VHO
   Santos, C
   Nascimento, LCJ
   Vilas-Boas, LS
   Amado, C
   Barbosa, PS
   Reis, JN
   Campos, GS
   Ribeiro, GS
   Siqueira, IC
   Silva, LK
   Reis, MG
AF Dias, T. T.
   Tauro, L. B.
   Macedo, L. E. N.
   Brito, L. O.
   Ribeiro, V. H. O.
   Santos, C.
   Nascimento, L. C. J.
   Vilas-Boas, L. S.
   Amado, C.
   Barbosa, P. S.
   Reis, J. N.
   Campos, G. S.
   Ribeiro, G. S.
   Siqueira, I. C.
   Silva, L. K.
   Reis, M. G.
TI The emergence of arboviruses changes the profile of viral meningitis in
   Salvador, Bahia
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
C1 [Dias, T. T.; Tauro, L. B.; Macedo, L. E. N.; Brito, L. O.; Santos, C.; Nascimento, L. C. J.; Vilas-Boas, L. S.; Amado, C.; Barbosa, P. S.; Reis, J. N.; Ribeiro, G. S.; Siqueira, I. C.; Silva, L. K.; Reis, M. G.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Ribeiro, V. H. O.; Campos, G. S.] Univ Fed Bahia, Salvador, BA, Brazil.
RI Reis, Mitermayer/AAO-9742-2020; de Siqueira, Isadora
   Cristina/R-9953-2016
OI Reis, Mitermayer/0000-0002-3051-9060; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA LB111
BP 1953
EP 1953
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026906277
DA 2020-12-09
ER

PT J
AU Rivera-Correa, J
   de Siqueira, IC
   Mota, S
   do Rosario, MS
   de Jesus, PAP
   Alcantara, LCJ
   Ernst, JD
   Rodriguez, A
AF Rivera-Correa, Juan
   de Siqueira, Isadora Cristina
   Mota, Sabrina
   do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Junior Alcantara, Luiz Carlos
   Ernst, Joel D.
   Rodriguez, Ana
TI Anti-ganglioside antibodies in patients with Zika virus
   infection-associated Guillain-Barre Syndrome in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; CAMPYLOBACTER-JEJUNI; AUTOIMMUNITY; AUTOANTIBODIES;
   OUTBREAK; AMERICA
AB Author summary Zika virus infection can trigger the development of Guillain Barre syndrome (GBS), a neurological autoimmune disorder mediated by antibodies recognizing gangliosides in nerve membranes. Mechanisms such as molecular mimicry have been identified as a cause for GBS development in certain infections, such as Campylobacter jejuni, but the broad self reactivity observed during GBS suggests a role for alternative mechanisms. Our finding that Zika patients with GBS present higher levels of anti-ganglioside antibodies compared to uncomplicated Zika patients in Brazil points to these auto-antibodies as a trigger for GBS in these patients. These findings further support infection-induced autoantibodies as a factor contributing to GBS development, adding novel mechanisms for GBS development beyond molecular mimicry.
   Zika virus infection is associated with the development of Guillain-Barre syndrome (GBS), a neurological autoimmune disorder caused by immune recognition of gangliosides and other components at nerve membranes. Using a high-throughput ELISA, we have analyzed the anti-glycolipid antibody profile, including gangliosides, of plasma samples from patients with Zika infections associated or not with GBS in Salvador, Brazil. We have observed that Zika patients that develop GBS present higher levels of anti-ganglioside antibodies when compared to Zika patients without GBS. We also observed that a broad repertoire of gangliosides was targeted by both IgM and IgG anti-self antibodies in these patients. Since Zika virus infects neurons, which contain membrane gangliosides, antigen presentation of these infected cells may trigger the observed autoimmune anti-ganglioside antibodies suggesting direct infection-induced autoantibodies as a cause leading to GBS development. Collectively, our results establish a link between anti-ganglioside antibodies and Zika-associated GBS in patients.
C1 [Rivera-Correa, Juan; Mota, Sabrina; Ernst, Joel D.; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
   [de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Pereira de Jesus, Pedro Antonio] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Junior Alcantara, Luiz Carlos] Fundaco Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Ernst, Joel D.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.
RP Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
EM ana.rodriguez@nyumc.org
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Rodriguez,
   Ana/0000-0002-0060-3405; Rivera-Correa, Juan/0000-0003-4822-0005;
   Alcantara, Luiz/0000-0002-6769-9931; do Rosario,
   Mateus/0000-0001-7404-6392; Ernst, Joel/0000-0001-9951-6207
FU New York University School of Medicine Internal Funds; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI100853, T32AI100853, T32AI100853, T32AI100853] Funding Source: NIH
   RePORTER
FX AR and JRC received funding for this project from New York University
   School of Medicine Internal Funds. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Arroyo-Avila M, 2017, AM J TROP MED HYG, V96, P916, DOI 10.4269/ajtmh.16-0890
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   do Rosario M, 2018, INT J INFECT DIS, V73, P49, DOI 10.1016/j.ijid.2018.04.3534
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flodstrom-Tullberg M, 2003, MICROBES INFECT, V5, P911, DOI 10.1016/S1286-4579(03)00161-8
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Koga M, 2015, J NEUROL, V262, P1954, DOI 10.1007/s00415-015-7806-4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Leuchten N, 2018, ARTHRIT CARE RES, V70, P428, DOI 10.1002/acr.23292
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Monsalve DM, 2017, AUTOIMMUN REV, V16, P1237, DOI 10.1016/j.autrev.2017.10.008
   Nico D, 2018, FRONT MED-LAUSANNE, V5, DOI [10.3389/fmed2018.00025, 10.3389/fmed.2018.00025]
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Ravindranath MH, 2005, ANN NY ACAD SCI, V1050, P229, DOI 10.1196/annals.1313.024
   Rinaldi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082337
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Steiner I, 2005, EUR J NEUROL, V12, P331, DOI 10.1111/j.1468-1331.2005.01126.x
   Tanay A, 2017, CURR OPIN RHEUMATOL, V29, P389, DOI 10.1097/BOR.0000000000000396
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Van Der Meche F. G. A., 1995, Annals of Neurology, V37, pS14
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
NR 37
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007695
DI 10.1371/journal.pntd.0007695
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100033
PM 31527907
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Freire, ML
   de Assis, TM
   Oliveira, E
   de Avelar, DM
   Siqueira, IC
   Barral, A
   Rabello, A
   Cota, G
AF Freire, Mariana Lourenco
   de Assis, Talia Machado
   Oliveira, Edward
   de Avelar, Daniel Moreira
   Siqueira, Isadora C.
   Barral, Aldina
   Rabello, Ana
   Cota, Glaucia
TI Performance of serological tests available in Brazil for the diagnosis
   of human visceral leishmaniasis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DIRECT AGGLUTINATION-TEST; SOLUBLE-ANTIGEN ELISA; RK39; DIPSTICK; IFAT
AB Background Visceral leishmaniasis (VL) is the most severe form of leishmaniasis and is potentially fatal if not diagnosed and treated. Accurate and timely diagnosis is considered one of the pillars needed for the reduction in disease-related lethality. Brazil is currently one of the three eco-epidemiological hotspots for this disease. Several serological tests are commercially available in this country for VL diagnosis, although information on the performance of these tests is fragmented and insufficient. The aim of this study was to directly compare the performance of six commercial kits: three enzyme-linked immunosorbent assays (ELISAs), two immunofluorescence antibody tests (IFATs), one immunochromatographic test (ICT), besides one ICT, currently not commercially available in Brazil and one in-house direct agglutination test (DAT-LPC), not yet marketed.
   Methodology/Principal findings A panel of 236 stored samples from patients with clinically suspected VL, including 77 HIV-infected patients, was tested. IT-LEISH and DAT-LPC showed the highest accuracy rate among the non-HIV-infected patients, 96.2% [CI95%: 92.8-99.7%] and 95.6% [CI95%: 91.9-99.3%], respectively. For the ELISA tests evaluated, the maximum accuracy was 91.2%, and in the inter HIV-status group analysis, no significant differences were observed. For both IFATs evaluated, the maximum accuracy was 84.3%, and a lower accuracy rate was observed among the HIV-infected patients (p = 0.039) than among the non-HIV-infected patients. The DAT-LPC was the most accurate test in the HIV-infected patients (p <= 0.115). In general, no significant difference in accuracy was observed among the VL-suspected patients stratified by age.
   Conclusions/Significance In summary, the differences in the performance of the tests available for VL in Brazil confirm the need for local studies before defining the diagnostic strategy.
   Author summary Visceral leishmaniasis (VL) is a tropical disease distributed worldwide. In the Americas, Brazil reports about 96% of VL cases, which has been highlighted by the increase in lethality in last years. Accurate VL diagnosis is of utmost importance. Despite this, the performance of some commercial tests currently available in Brazil is unknown, especially for HIV-infected patients. Accordingly, in this study we present a comparative performance analysis of six commercial kits available in Brazil for the diagnosis of VL in non-HIV and HIV-infected patients, besides one immunochromatographic test (ICT) and one in-house direct agglutination test (DAT-LPC) currently not commercially available in Brazil. ICTs and DAT-LPC showed better performance among non-HIV infected patients. Despite the known limitation of serological tests for the diagnosis of patients with HIV, the direct agglutination test was more accurate in this specific group of patients. Our results demonstrate significant differences in the performance of different serological tests and confirm that the use of serology should be qualified with previous information on the performance of the tests.
C1 [Freire, Mariana Lourenco; de Assis, Talia Machado; Oliveira, Edward; de Avelar, Daniel Moreira; Rabello, Ana; Cota, Glaucia] Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infecciosas &, Belo Horizonte, MG, Brazil.
   [de Assis, Talia Machado] Ctr Fed Educ Tecnol Minas Gerais, Contagem, MG, Brazil.
   [Siqueira, Isadora C.] Fundacao Oswaldo Cruz, Inst Goncalo Muniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Barral, Aldina] Fundacao Oswaldo Cruz, Inst Goncalo Muniz, Lab Enfermidades Infecciosas Transmitidas Vetores, Salvador, BA, Brazil.
RP Freire, ML (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infecciosas &, Belo Horizonte, MG, Brazil.
EM marianalfreire@hotmail.com
RI de Siqueira, Isadora Cristina/R-9953-2016; Cota, Glaucia/ABC-5378-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Cota,
   Glaucia/0000-0003-0538-7403; Freire, Mariana
   Lourenco/0000-0003-3380-2651
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [APQ-00991-15]; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [310938/2017-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES [001]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES), BrasilCAPES [001]
FX AR received grant number APQ-00991-15 by the Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG), http://www.fapemig.br.AR
   received grant number 310938/2017-1 by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), http://www.cnpq.br.MLF
   received grant number Finance Code 001 by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   https://www.capes.gov.br. This study was partially funded by Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasil -
   Finance Code 001. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bangert M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006277
   Banu Sultana Shahana, 2016, Parasite Epidemiol Control, V1, P219, DOI 10.1016/j.parepi.2016.07.003
   da Silva MRB, 2018, PARASITOL RES, V117, P419, DOI 10.1007/s00436-017-5716-3
   Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527
   Brasil-Ministerio da Saude do Brasil, 2014, MAN VIG CONTR LEISHM
   Brasil-Ministerio da Saude do Brasil, 2018, SIST INF MORT
   Chappuis F, 2006, BMJ-BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C
   Costa G, 2018, LANCET INFECT DIS, V18, P614, DOI [10.1016/S1473-3099(18)30307-4, DOI 10.1016/S1473-3099(18)30307-4]
   Cota GF, 2013, AM J TROP MED HYG, V89, P570, DOI 10.4269/ajtmh.13-0239
   Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665
   Cruz I, 2006, J CLIN MICROBIOL, V44, P2343, DOI 10.1128/JCM.02297-05
   Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716
   El Safi SH, 2007, NATURE REV MICROBIOL, V5, pS30, DOI DOI 10.1038/NRMICRO1766
   Ghosh P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0935-x
   Lindoso JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003136
   Mikaeili Fattaneh, 2007, Iran J Immunol, V4, P116
   Mniouil M, 2018, ACTA TROP, V182, P185, DOI 10.1016/j.actatropica.2018.03.007
   Oliveira E, 2017, PARASITOLOGY, V144, P1964, DOI [10.1017/S0031182017001378, 10.1017/s0031182017001378]
   Oliveira E, 2011, T ROY SOC TROP MED H, V105, P414, DOI 10.1016/j.trstmh.2011.04.010
   PAHO. Pan-American Health Organization, 2018, LEISHM EP REP AM
   Pedras MJ, 2008, T ROY SOC TROP MED H, V102, P172, DOI 10.1016/j.trstmh.2007.11.004
   Peruhype-Magalhaes V, 2012, MEM I OSWALDO CRUZ, V107, P951, DOI 10.1590/S0074-02762012000700019
   Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006
   ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929
   WHO, 2018, EP SIT LEISHM
   WHO-World Health Organization, 2008, US VISC LEISHM RAP D
   World Health Organization, 2012, REG STRAT FRAM EL KA
   2010, WHO TECH REP SER, V949, P1
NR 28
TC 12
Z9 12
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2019
VL 13
IS 7
AR e0007484
DI 10.1371/journal.pntd.0007484
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IN4RG
UT WOS:000478662500020
PM 31318856
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Fonseca, V
   Libin, PJK
   Theys, K
   Faria, NR
   Nunes, MRT
   Restovic, MI
   Freire, M
   Giovanetti, M
   Cuypers, L
   Nowe, A
   Abecasis, A
   Deforche, K
   Santiago, GA
   de Siqueira, IC
   San, EJ
   Machado, KCB
   Azevedo, V
   Bispo-de Filippis, AM
   da Cunha, RV
   Pybus, OG
   Vandamme, AM
   Alcantara, LCJ
   de Oliveira, T
AF Fonseca, Vagner
   Libin, Pieter J. K.
   Theys, Kristof
   Faria, Nuno R.
   Nunes, Marcio R. T.
   Restovic, Maria I.
   Freire, Murilo
   Giovanetti, Marta
   Cuypers, Lize
   Nowe, Ann
   Abecasis, Ana
   Deforche, Koen
   Santiago, Gilberto A.
   de Siqueira, Isadora C.
   San, Emmanuel J.
   Machado, Kaliane C. B.
   Azevedo, Vasco
   Bispo-de Filippis, Ana Maria
   da Cunha, Rivaldo Venancio
   Pybus, Oliver G.
   Vandamme, Anne-Mieke
   Alcantara, Luiz C. J.
   de Oliveira, Tulio
TI A computational method for the identification of Dengue, Zika and
   Chikungunya virus species and genotypes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOLECULAR EPIDEMIOLOGY; LARGE PHYLOGENIES; PERFORMANCE; ACCURATE;
   BURDEN; SYSTEM; HIV-1
AB In recent years, an increasing number of outbreaks of Dengue, Chikungunya and Zika viruses have been reported in Asia and the Americas. Monitoring virus genotype diversity is crucial to understand the emergence and spread of outbreaks, both aspects that are vital to develop effective prevention and treatment strategies. Hence, we developed an efficient method to classify virus sequences with respect to their species and sub-species (i.e. serotype and/or genotype). This tool provides an easy-to-use software implementation of this new method and was validated on a large dataset assessing the classification performance with respect to whole-genome sequences and partial-genome sequences. Available online: http://krisp.org.za/tools.php.
   Author summary Dengue (DENV), Chikungunya (CHIKV) and Zika (ZIKV) are considered major public health challenges. In addition to the epidemic caused by DENV, which has been described in many tropical countries, the introduction of CHIKV and ZIKV in these countries is a major public health concern. These arboviruses are primarily transmitted by mosquitoes of the species Ae. Aegypti and its related diseases result in increased financial costs associated with diagnosis and treatment. To support the design of efficient diagnosis, prevention and treatment strategies, a bioinformatics tool has been developed for the genotyping of these viruses based on appropriate evolutionary models in an automatic, accurate and rapid manner. A set of virus reference sequences was obtained from GenBank and used for the development of the tools. This process involved the alignment of the reference sequences followed by phylogenetic tree reconstructions. To assign the genotypes uploaded by the user, the tool analyses the sequences one by one, genotypes through identification, alignment and phylogenetic reconstruction. This computational method allows the high-throughput classification of these virus species and genotypes in seconds. As shown experimentally, genotypes are classified most confidently using the envelope gene or complete genome sequences.
C1 [Fonseca, Vagner; Giovanetti, Marta; Bispo-de Filippis, Ana Maria; Alcantara, Luiz C. J.] Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Fonseca, Vagner; San, Emmanuel J.; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Fonseca, Vagner; Azevedo, Vasco; Alcantara, Luiz C. J.] Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Libin, Pieter J. K.; Nowe, Ann] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium.
   [Libin, Pieter J. K.; Theys, Kristof; Cuypers, Lize; Vandamme, Anne-Mieke] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Restovic, Maria I.; Freire, Murilo; de Siqueira, Isadora C.; Machado, Kaliane C. B.] Fundacao Oswaldo Cruz, Lab Patol Expt, Salvador, BA, Brazil.
   [Abecasis, Ana; Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, Ctr Global Hlth & Trop Med, Lisbon, Portugal.
   [Deforche, Koen] EMWEB Private Co, Herent, Belgium.
   [Santiago, Gilberto A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Coordenacao Vigilancia Saude & Lab Referencias, Rio De Janeiro, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.; de Oliveira, T (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com; tuliodna@gmail.com
RI de Siqueira, Isadora Cristina/R-9953-2016; Fonseca, Vagner/R-5813-2019;
   Pybus, Oliver G/B-2640-2012; Azevedo, Vasco A/B-1556-2019; Abecasis,
   Ana/ABF-6657-2020; Faria, Nuno R/I-2975-2012; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Fonseca,
   Vagner/0000-0001-5521-6448; Pybus, Oliver G/0000-0002-8797-2667;
   Azevedo, Vasco A/0000-0002-4775-2280; Abecasis, Ana/0000-0002-3903-5265;
   Faria, Nuno R/0000-0001-8839-2798; Alcantara, Luiz/0000-0002-6769-9931;
   Nowe, Ann/0000-0001-6346-4564
FU South African Medical Re-search Council [MRC-RFA-UFSP-01-2013/UKZN
   HIVEPI]; Royal Society Newton Advanced Fellowship; VIROGENESIS project -
   European Union's Horizon 2020 Research and Innovation Programme
   [634650]; National Institutes of Health Common FundUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U24HG006941]; FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen)FWO; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/201600, 88881.130825/2016-00, 88887.130823/2016-00]; EU's
   Horizon 2020 Programme through ZIKAlliance [PRES-005-FEX-17-4-2-33];
   Fundacao para a Ciencia e Tecnologia (FCT)Portuguese Foundation for
   Science and Technology [GHTM-UID/Multi/04413/2013]; Decit/SCTIE/MoH;
   NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Human Genome Research Institute (NHGRI) [U24HG006941,
   U24HG006941, U24HG006941, U24HG006941, U24HG006941] Funding Source: NIH
   RePORTER
FX Supported by a research Flagship grant from the South African Medical
   Re-search Council (MRC-RFA-UFSP-01-2013/UKZN HIVEPI), a Royal Society
   Newton Advanced Fellowship (TdO), the VIROGENESIS project receives
   funding from the European Union's Horizon 2020 Research and Innovation
   Programme (under Grant Agreement no. 634650) and the National Institutes
   of Health Common Fund, grant number U24HG006941. Pieter Libin was
   supported by a PhD grant of the FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen). This work was supported by Decit/SCTIE/MoH and CNPq
   (440685/2016-8 and 440856/2016-7); by CAPES (88887.130716/201600,
   88881.130825/2016-00 and 88887.130823/2016-00); and by EU's Horizon 2020
   Programme through ZIKAlliance (PRES-005-FEX-17-4-2-33). Ana Abecasis was
   supported by Fundacao para a Ciencia e Tecnologia (FCT) through funds to
   GHTM-UID/Multi/04413/2013. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altschul SF, 1990, BASIC LOCAL ALIGNMEN
   [Anonymous], 2018, STROKE, V49, pe233
   Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
   Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gks1195, 10.1093/nar/gkt1030, 10.1093/nar/gkr1202]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CHUNGUE E, 1993, J GEN VIROL, V74, P2765, DOI 10.1099/0022-1317-74-12-2765
   Cuypers L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100569
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Ha Schmidt, 2002, BIOINFORMATICS, V18, P502, DOI [10.1093/bioinformatics/18.3.502, DOI 10.1093/BIOINFORMATICS/18.3.502]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Libin P., 2018, BIOINFORMATICS OXFOR
   Libin P, 2017, BIOINFORMATICS, V33, P3993, DOI 10.1093/bioinformatics/btx535
   Libin P, 2013, BIOINFORMATICS, V29, P1477, DOI 10.1093/bioinformatics/btt162
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Morens DM, 2016, J INFECT DIS, V214, pS434, DOI 10.1093/infdis/jiw291
   Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Salemi M., 2003, PHYLOGENETIC HDB PRA
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theys K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006528
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Vilsker M, 2019, BIOINFORMATICS, V35, P871, DOI 10.1093/bioinformatics/bty695
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 45
TC 6
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007231
DI 10.1371/journal.pntd.0007231
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100009
PM 31067235
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU de Almeida, BL
   Giovanetti, M
   Oliveira, JV
   Xavier, TC
   Figueiredo, EM
   Goes, JJ
   Alcantara, LC
   de Siqueira, IC
AF de Almeida, Breno L.
   Giovanetti, Marta
   Oliveira, Joao V.
   Xavier, Tereza C.
   Figueiredo, Eduardo M.
   Goes, Jaqueline J.
   Alcantara, Luiz C.
   de Siqueira, Isadora C.
TI DETECTION AND SEQUENCING OF ZIKA VIRUS IN NORMOCEPHALIC NEWBORNS WITH
   CONGENITAL ZIKA IN FECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [de Almeida, Breno L.; Giovanetti, Marta; Oliveira, Joao V.; Goes, Jaqueline J.; Alcantara, Luiz C.; de Siqueira, Isadora C.] Fundacao Oswaldo Cruz Fiocruz, Salvador, BA, Brazil.
   [Xavier, Tereza C.] Maternidade Referencia Prof Jose Maria de Maglhae, Salvador, BA, Brazil.
   [Figueiredo, Eduardo M.] Maternidade Referencia Prof Jose Maria de Magalha, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 209
BP 63
EP 63
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502209
DA 2020-12-09
ER

PT J
AU do Rosario, MS
   Giovanetti, M
   de Jesus, PAP
   Farias, DS
   Faria, NR
   de Lima, CPS
   da Silva, SP
   Nunes, MR
   Alcantara, LC
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Giovanetti, Marta
   Pereira de Jesus, Pedro Antonio
   Farias, Daniel Santana
   Faria, Nuno R.
   de Lima, Clayton Pereira S.
   da Silva, Sandro Patroca
   Nunes, Marcio Roberto
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and
   dengue virus co-infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Opsoclonus; Chikungunya; Dengue
ID NEUROLOGICAL MANIFESTATIONS; INFECTION; DIAGNOSIS
AB Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare neurological disorder characterized by irregular multidirectional eye movements, myoclonus, cerebellar ataxia, sleep disturbances, and cognitive dysfunction. Although most commonly related to paraneoplastic syndrome, this condition has occasionally been described following infectious illnesses. This article reports the first case of OMAS in association with chikungunya and dengue virus co-infection. The genetic analysis identified chikungunya virus of East/Central/South African genotype and dengue serotype 4 virus of genotype II. This report represents an unusual clinical syndrome associated with viral co-infection and reinforces the need for clinical vigilance with regard to neurological syndromes in the context of emergent arboviruses. (c) 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [do Rosario, Mateus Santana; Giovanetti, Marta; Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana; Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Pereira de Jesus, Pedro Antonio] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford, England.
   [de Lima, Clayton Pereira S.; da Silva, Sandro Patroca; Nunes, Marcio Roberto] Inst Evandro Chagas, Ctr Tecnol & Inovacao, Ananindeua, Para, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI Giovanetti, Marta/AAK-7408-2020; de Siqueira, Isadora
   Cristina/R-9953-2016; Faria, Nuno R/I-2975-2012
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Faria, Nuno
   R/0000-0001-8839-2798; Alcantara, Luiz/0000-0002-6769-9931; Jesus, Pedro
   Antonio/0000-0003-1211-2272; do Rosario, Mateus/0000-0001-7404-6392
FU CNPq-National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [302584/2015-3]; MCTI-Ministry of Science, Technology,
   Innovation/FINEP-Funding Authority for Studies and
   Projects/FNDCT-National Fund for the Development of Science and
   Technology [04160060-00/2016]
FX CNPq-National Council for Scientific and Technological Development
   (302584/2015-3) and MCTI-Ministry of Science, Technology,
   Innovation/FINEP-Funding Authority for Studies and
   Projects/FNDCT-National Fund for the Development of Science and
   Technology (04160060-00/2016)
CR Bintner M, 2015, NEUROLOGY, P2005
   Blaes F, 2008, J NEUROIMMUNOL, V201, P221, DOI 10.1016/j.jneuroim.2008.05.033
   Cao-Lormeau V. M., 2016, LANCET
   Chiam CW, 2013, DIAGN MICR INFEC DIS, V77, P133, DOI 10.1016/j.diagmicrobio.2013.06.018
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Gorman MP, 2010, CURR OPIN PEDIATR, V22, P745, DOI 10.1097/MOP.0b013e32833fde3f
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tan AH, 2014, PARKINSONISM RELAT D, V20, P1309, DOI 10.1016/j.parkreldis.2014.09.002
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
NR 15
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2018
VL 75
BP 11
EP 14
DI 10.1016/j.ijid.2018.07.019
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA GV6IS
UT WOS:000446213000003
PM 30076990
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   de Maia, ML
   Junior, JX
   Amarante, MFC
   Viana, P
   Barreto, FK
   de Cerqueira, EM
   Santos, NP
   Falcao, MB
   Costa, MCM
   Faical, AVB
   de Melo, ALA
   Amorim, LS
   de Siqueira, IC
   Macarenhas, DL
   de Filippis, AMB
   Faria, NR
   Acosta, AX
   Alcantara, LCJ
AF Giovanetti, M.
   Goes de Jesus, J.
   Lima de Maia, M.
   Junior, J. X.
   Castro Amarante, M. F.
   Viana, P.
   Khouri Barreto, F.
   de Cerqueira, E. M.
   Pedreira Santos, N.
   Barreto Falcao, M.
   Machado Costa, M. C.
   Barros Faical, A. V.
   Andrade de Melo, A. L.
   Santos Amorim, L.
   de Siqueira, I. C.
   Macarenhas, D. L.
   Bispo de Filippis, A. M.
   Faria, N. Rodrigues
   Xavier Acosta, A.
   Junior Alcantara, L. C.
TI Genetic evidence of Zika virus in mother's breast milk and body fluids
   of a newborn with severe congenital defects
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Giovanetti, M.; Goes de Jesus, J.; Junior, J. X.; Castro Amarante, M. F.; Viana, P.; Khouri Barreto, F.; Santos Amorim, L.; Junior Alcantara, L. C.] Inst Goncalo Moniz Salvador, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, M.; Bispo de Filippis, A. M.; Junior Alcantara, L. C.] Fiocruz MS, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Lima de Maia, M.; de Cerqueira, E. M.] Univ Estadual Feira de Santana, Salvador, BA, Brazil.
   [Lima de Maia, M.; Pedreira Santos, N.; Barreto Falcao, M.; Machado Costa, M. C.; Andrade de Melo, A. L.; Macarenhas, D. L.] Secretaria Saude Feira Santana, Salvador, BA, Brazil.
   [Barreto Falcao, M.; Xavier Acosta, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Faria, N. Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Fundac Oswaldo Cruz, Rio De Janeiro, Brazil.
EM lalcan@bahia.fiocruz.br
RI Faria, Nuno R/I-2975-2012; de Siqueira, Isadora Cristina/R-9953-2016;
   Giovanetti, Marta/AAK-7408-2020
OI Faria, Nuno R/0000-0001-8839-2798; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Alcantara, Luiz/0000-0002-6769-9931;
   Xavier, Joilson/0000-0003-3916-2018; Castro Amarante, Maria
   Fernanda/0000-0003-2162-9505
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX Supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). All authors report no conflicts of interest
   relevant to this article.
CR de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dupont-Rouzeyrol M, 2016, LANCET LOND ENGL, V387, P1051
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 5
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD OCT
PY 2018
VL 24
IS 10
BP 1111
EP 1112
DI 10.1016/j.cmi.2018.06.008
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GU0EY
UT WOS:000444923000026
PM 29906587
OA Bronze
DA 2020-12-09
ER

PT J
AU do Rosario, MS
   de Jesus, PAP
   Farias, DS
   Novaes, MAC
   Santos, CS
   Azar, SR
   Vasilakis, N
   de Moura, DL
   Lima, FWD
   Alcantara, LC
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Farias, Daniel Santana
   Caires Novaes, Marco Antonio
   Santos, Cleiton Silva
   Azar, Sasha R.
   Vasilakis, Nikos
   de Moura, Daniel Lima
   Lima, Fernanda Washington de M.
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Reversible sensory polyneuropathy during an arboviral outbreak in
   Salvador, Bahia, Brazil
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
DE Reversible sensory polyneuropathy; Zika virus; Chikungunya virus
ID NEUROLOGICAL MANIFESTATIONS; CHIKUNGUNYA
C1 [do Rosario, Mateus Santana; Santos, Cleiton Silva; Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Hosp Geral Roberto Santos, Secretaria Estadual Scude Bahia, Salvador, BA, Brazil.
   [Caires Novaes, Marco Antonio] Hosp Sao Rafael, Fundacao Monte Tabor, Salvador, BA, Brazil.
   [Azar, Sasha R.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis,Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [de Moura, Daniel Lima; Lima, Fernanda Washington de M.] Univ Fed Bahia, Lab Imunol Doencas Infecciosas, Fac Farm, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; do Rosario,
   Mateus/0000-0001-7404-6392; Jesus, Pedro Antonio/0000-0003-1211-2272;
   Alcantara, Luiz/0000-0002-6769-9931
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942, 1U01A1115577];
   MCTI/FINEP/FNDCT-Brazil grant [04160060-00/2016]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01AI115577,
   R24AI120942, R24AI120942, R24AI120942, R24AI120942, U01AI115577,
   U01AI115577, R24AI120942] Funding Source: NIH RePORTER
FX Zika work is supported in part by NIH grants R24AI120942 and
   1U01A1115577 (NV) and MCTI/FINEP/FNDCT-Brazil grant 04160060-00/2016
   (LCJA).
CR Acevedo N., 2017, FRONT MICROBIOL, V8, P1
   [Anonymous], 2016, PROC SER AD VIG FEBR
   CDC, ZIK MAC ELISA
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Mehta R., 2018, SPECTRUM NEUROLOGICA
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282X20160138, 10.1590/0004-282x20160138]
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
NR 12
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD AUG 15
PY 2018
VL 391
BP 3
EP 4
DI 10.1016/j.jns.2018.05.009
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GO0YL
UT WOS:000439672500002
PM 30103966
DA 2020-12-09
ER

PT J
AU Cabral, J
   Faical, A
   Almeida, B
   Oliveira, JV
   Embirucu, E
   Ferreira, N
   Reis, L
   Salles, C
   Cabral, B
   Costa, B
   Francisco, MV
   Santos, C
   Alcantara, LC
   Acosta, A
   Siqueira, I
AF Cabral, J.
   Faical, A.
   Almeida, B.
   Oliveira, J. V.
   Embirucu, E.
   Ferreira, N.
   Reis, L.
   Salles, C.
   Cabral, B.
   Costa, B.
   Francisco, M. V.
   Santos, C.
   Alcantara, L. C.
   Acosta, A.
   Siqueira, I.
TI Neurodevelopmental delays arising from in utero exposure to Zika virus
   in Salvador, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Cabral, J.; Almeida, B.; Costa, B.; Francisco, M. V.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Faical, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Oliveira, J. V.; Santos, C.] Inst Goncalo Moniz Fiocruz, Salvdor, Brazil.
   [Embirucu, E.; Ferreira, N.; Reis, L.; Salles, C.; Cabral, B.; Acosta, A.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 1
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.002
BP 48
EP 49
DI 10.1016/j.ijid.2018.04.3533
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100099
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU do Rosario, M
   Jesus, P
   Farias, D
   Novaes, MA
   Moura, D
   Lima, F
   Santos, C
   Giovanetti, M
   Alcantara, LC
   Siqueira, I
AF do Rosario, M.
   Jesus, P.
   Farias, D.
   Novaes, M. A.
   Moura, D.
   Lima, F.
   Santos, C.
   Giovanetti, M.
   Alcantara, L. C.
   Siqueira, I.
TI Neurological complications associated with arboviruses during Zika
   outbreak in Salvador, Bahia-Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [do Rosario, M.; Santos, C.; Giovanetti, M.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Jesus, P.] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Farias, D.] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Novaes, M. A.] Hosp Sao Rafael, Salvador, BA, Brazil.
   [Moura, D.; Lima, F.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.004
BP 49
EP 49
DI 10.1016/j.ijid.2018.04.3534
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100100
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Almeida, B
   Cabral, J
   Faical, A
   Oliveira, JV
   Souza, M
   Salles, C
   Vianna, MI
   D'Agostino, E
   Ferreira, N
   Reis, L
   Embirucu, E
   Santos, C
   Duarte, A
   Acosta, A
   Siqueira, I
AF Almeida, B.
   Cabral, J.
   Faical, A.
   Oliveira, J. V.
   Souza, M.
   Salles, C.
   Vianna, M. I.
   D'Agostino, E.
   Ferreira, N.
   Reis, L.
   Embirucu, E.
   Santos, C.
   Duarte, A.
   Acosta, A.
   Siqueira, I.
TI Discordant congenital Zika virus infection in dizygotic twins: a case
   report
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Almeida, B.; Cabral, J.; Oliveira, J. V.; Santos, C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Faical, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Souza, M.; Salles, C.; Vianna, M. I.; D'Agostino, E.; Ferreira, N.; Reis, L.; Embirucu, E.; Acosta, A.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Duarte, A.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA Sat_Statio
BP 107
EP 107
DI 10.1016/j.ijid.2018.04.3662
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100228
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Oliveira, JV
   Duarte, A
   Santos, C
   Pessoa, L
   Magalhaes, C
   Lima, J
   Carvalho, D
   Xavier, T
   Figueiredo, E
   Giovanetti, M
   Almeida, B
   Goes, J
   Lima, F
   Alcantara, LC
   Siqueira, I
AF Oliveira, J. V.
   Duarte, A.
   Santos, C.
   Pessoa, L.
   Magalhaes Filho, C.
   Lima, J.
   Carvalho, D.
   Xavier, T.
   Figueiredo, E.
   Giovanetti, M.
   Almeida, B.
   Goes, J.
   Lima, F.
   Alcantara, L. C.
   Siqueira, I.
TI Prevalence of Zika, dengue and Chikungunya virus infection in pregnant
   women and surveillance of congenital Zika infection in Salvador, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Oliveira, J. V.; Santos, C.; Pessoa, L.; Magalhaes Filho, C.; Lima, J.; Carvalho, D.; Giovanetti, M.; Almeida, B.; Goes, J.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvdor, Brazil.
   [Duarte, A.; Lima, F.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
   [Xavier, T.; Figueiredo, E.] Maternidade Referencia Prof Jose Maria Magalhaes, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; amsalu, ribka/G-8780-2019;
   Giovanetti, Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 202
BP 182
EP 182
DI 10.1016/j.ijid.2018.04.3826
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100392
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Faical, AV
   de Oliveira, JM
   de Almeida, BL
   Leao, EK
   Oliveira, JV
   Andrade, I
   Cabral, MB
   Ferreira, NS
   Reis, LO
   Salles, C
   Costa, BG
   Francisco, MV
   Santos, CS
   D'Agostinho, E
   Vianna, MI
   Duarte, AO
   Acosta, AX
   de Siqueira, IC
AF Faical, Adriana
   de Oliveira, Juliana
   de Almeida, Breno
   Leao, Emila
   Oliveira, Joao
   Andrade, Iluska
   Cabral, Maria
   Ferreira, Nelfa
   Reis, Lucas
   Salles, Cristina
   Costa, Bernardo
   Francisco, Marcus
   Santos, Cleiton
   D'Agostinho, Erica
   Vianna, Maria
   Duarte, Alan
   Acosta, Angelina
   de Siqueira, Isadora
TI NEURODEVELOPMENTAL DELAYS ARISING FROM <it>IN UTERO</it> EXPOSURE TO
   ZIKA VIRUS IN SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Faical, Adriana; Leao, Emila; Andrade, Iluska; Salles, Cristina; Acosta, Angelina] Univ Fed Bahia, Salvador, BA, Brazil.
   [de Oliveira, Juliana; de Almeida, Breno; Oliveira, Joao; Ferreira, Nelfa; Reis, Lucas; Costa, Bernardo; Francisco, Marcus; Santos, Cleiton; Duarte, Alan; de Siqueira, Isadora] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Cabral, Maria; D'Agostinho, Erica; Vianna, Maria] Univ Fed Bahia, Fac Odontol, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 215
BP 67
EP 67
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602216
DA 2020-12-09
ER

PT J
AU Faria, NR
   Quick, J
   Claro, IM
   Theze, J
   de Jesus, JG
   Giovanetti, M
   Kraemer, MUG
   Hill, SC
   Black, A
   da Costa, AC
   Franco, LC
   Silva, SP
   Wu, CH
   Raghwani, J
   Cauchemez, S
   du Plessis, L
   Verotti, MP
   de Oliveira, WK
   Carmo, EH
   Coelho, GE
   Santelli, ACFS
   Vinhal, LC
   Henriques, CM
   Simpson, JT
   Loose, M
   Andersen, KG
   Grubaugh, ND
   Somasekar, S
   Chiu, CY
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Arias, CF
   Lewis-Ximenez, LL
   Baylis, SA
   Chieppe, AO
   Aguiar, SF
   Fernandes, CA
   Lemos, PS
   Nascimento, BLS
   Monteiro, HAO
   Siqueira, IC
   de Queiroz, MG
   de Souza, TR
   Bezerra, JF
   Lemos, MR
   Pereira, GF
   Loudal, D
   Moura, LC
   Dhalia, R
   Franca, RF
   Magalhaes, T
   Marques, ET
   Jaenisch, T
   Wallau, GL
   de Lima, MC
   Nascimento, V
   de Cerqueira, EM
   de Lima, MM
   Mascarenhas, DL
   Neto, JPM
   Levin, AS
   Tozetto-Mendoza, TR
   Fonseca, SN
   Mendes-Correa, MC
   Milagres, FP
   Segurado, A
   Holmes, EC
   Rambaut, A
   Bedford, T
   Nunes, MRT
   Sabino, EC
   Alcantara, LCJ
   Loman, NJ
   Pybus, OG
AF Faria, N. R.
   Quick, J.
   Claro, I. M.
   Theze, J.
   de Jesus, J. G.
   Giovanetti, M.
   Kraemer, M. U. G.
   Hill, S. C.
   Black, A.
   da Costa, A. C.
   Franco, L. C.
   Silva, S. P.
   Wu, C. -H.
   Raghwani, J.
   Cauchemez, S.
   du Plessis, L.
   Verotti, M. P.
   de Oliveira, W. K.
   Carmo, E. H.
   Coelho, G. E.
   Santelli, A. C. F. S.
   Vinhal, L. C.
   Henriques, C. M.
   Simpson, J. T.
   Loose, M.
   Andersen, K. G.
   Grubaugh, N. D.
   Somasekar, S.
   Chiu, C. Y.
   Munoz-Medina, J. E.
   Gonzalez-Bonilla, C. R.
   Arias, C. F.
   Lewis-Ximenez, L. L.
   Baylis, S. A.
   Chieppe, A. O.
   Aguiar, S. F.
   Fernandes, C. A.
   Lemos, P. S.
   Nascimento, B. L. S.
   Monteiro, H. A. O.
   Siqueira, I. C.
   de Queiroz, M. G.
   de Souza, T. R.
   Bezerra, J. F.
   Lemos, M. R.
   Pereira, G. F.
   Loudal, D.
   Moura, L. C.
   Dhalia, R.
   Franca, R. F.
   Magalhaes, T.
   Marques, E. T., Jr.
   Jaenisch, T.
   Wallau, G. L.
   de Lima, M. C.
   Nascimento, V.
   de Cerqueira, E. M.
   de Lima, M. M.
   Mascarenhas, D. L.
   Moura Neto, J. P.
   Levin, A. S.
   Tozetto-Mendoza, T. R.
   Fonseca, S. N.
   Mendes-Correa, M. C.
   Milagres, F. P.
   Segurado, A.
   Holmes, E. C.
   Rambaut, A.
   Bedford, T.
   Nunes, M. R. T.
   Sabino, E. C.
   Alcantara, L. C. J.
   Loman, N. J.
   Pybus, O. G.
TI Establishment and cryptic transmission of Zika virus in Brazil and the
   Americas
SO NATURE
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; EVOLUTION; TIME; EMERGENCE; MODELS; DENGUE;
   BAHIA; RECOMBINATION; SEQUENCES; SELECTION
AB Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil(1). Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 20162) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 20162). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease(3). However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.
C1 [Faria, N. R.; Theze, J.; Kraemer, M. U. G.; Hill, S. C.; Raghwani, J.; du Plessis, L.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England.
   [Faria, N. R.; Franco, L. C.; Silva, S. P.; Lemos, P. S.; Nascimento, B. L. S.; Monteiro, H. A. O.; Nunes, M. R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [de Jesus, J. G.; Giovanetti, M.; Siqueira, I. C.; Alcantara, L. C. J.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, M.] Univ Roma Tor Vergata, Rome, Italy.
   [Kraemer, M. U. G.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Black, A.; Bedford, T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford OX1 3LB, England.
   [Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Cauchemez, S.] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Cauchemez, S.] Ctr Natl Rech Sci, URA3012, Paris, France.
   [Verotti, M. P.] Minist Hlth, Coordena Lab Saude CGLAB DEVIT SVS, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Minist Hlth, Coordena Geral Vigilincia & Resposta Emergencias, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.
   [Carmo, E. H.; Henriques, C. M.] Minist Hlth, Dept Vigilincia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Coelho, G. E.; Santelli, A. C. F. S.; Vinhal, L. C.] Minist Hlth, Coordena Geral Programas Controle & Preven Malari, Brasilia, DF, Brazil.
   [Coelho, G. E.] PAHO, Buenos Aires, DF, Argentina.
   [Santelli, A. C. F. S.] Fundacao Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Simpson, J. T.] Ontario Inst Canc Res, Toronto, ON, Canada.
   [Loose, M.] Univ Nottingham, Nottingham, England.
   [Andersen, K. G.; Grubaugh, N. D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Med Infect & Dis, San Francisco, CA 94143 USA.
   [Munoz-Medina, J. E.; Gonzalez-Bonilla, C. R.] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico.
   [Arias, C. F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Lewis-Ximenez, L. L.] Inst Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Baylis, S. A.] Paul Ehrlich Inst, Langen, Germany.
   [Chieppe, A. O.; Aguiar, S. F.; Fernandes, C. A.] Lab Cent Saude Publ Noel Nutels, Rio De Janeiro, Brazil.
   [de Queiroz, M. G.; de Souza, T. R.; Bezerra, J. F.] Labo Cent Saude Publ Estado Rio Grande Norte, Natal, RN, Brazil.
   [de Souza, T. R.] Univ Potiguar Rio Grande Norte, Natal, RN, Brazil.
   [Bezerra, J. F.] Fundacao Natalense Ensino & Cultura, Natal, RN, Brazil.
   [Lemos, M. R.; Pereira, G. F.; Loudal, D.; Moura, L. C.] Lab Cent Saude Publ Estado Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Dhalia, R.; Franca, R. F.; Magalhaes, T.; Marques, E. T., Jr.; Wallau, G. L.] Fundacao Oswaldo Cruz FIOCRUZ, Recife, PE, Brazil.
   [Magalhaes, T.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Jaenisch, T.] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [de Lima, M. C.; Nascimento, V.; de Cerqueira, E. M.] Lab Cent Saude Publ Estado Alagoas, Maceio, Brazil.
   [de Lima, M. M.] Univ Estadual Feira de Santana, Feira Santana, Bahia, Argentina.
   [Mascarenhas, D. L.] Secretaria Saude Feira Santana, Feira De Santana, Bahia, Brazil.
   [Moura Neto, J. P.] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Fonseca, S. N.] Hosp Sao Francisco, Ribeirao Preto, Brazil.
   [Milagres, F. P.] Univ Fed Tocantins, Palmas, Brazil.
   [Holmes, E. C.] Univ Sydney, Sydney, NSW, Australia.
   [Rambaut, A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, A.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Nunes, M. R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Pybus, O. G.] Metabiota, San Francisco, CA 94104 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SY, England.; Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Sabino, EC (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.; Sabino, EC (corresponding author), Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.; Alcantara, LCJ (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.
EM sabinoec@usp.br; lalcan@bahia.fiocruz.br; n.j.loman@bham.ac.uk;
   oliver.pybus@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Rambaut, Andrew/B-2481-2009; Faria, Nuno
   R/I-2975-2012; Magalhaes, Tereza/V-6632-2019; Dhalia,
   Rafael/AAD-5432-2020; Levin, Anna S/C-8831-2012; Arias,
   Carlos/O-4036-2019; Esteban, Munoz Medina Jose/B-6186-2015; Giovanetti,
   Marta/AAK-7408-2020; milagres, flavio/Q-2403-2019; da-Costa, Antonio
   Charlys/G-1548-2010; Loman, Nicholas/Z-1573-2019; de Siqueira, Isadora
   Cristina/R-9953-2016; Bezerrra, Joao/C-8867-2017; Sabino, Ester
   Cerdeira/F-7750-2010; Bezerra, Joao Felipe/AAE-2500-2020; Segurado,
   Aluisio C/K-2229-2012; Wallau, Gabriel Luz/B-5911-2008; Marques, Ernesto
   T. A/L-4967-2013; Oliveira, Claudia DL/G-8618-2011
OI Pybus, Oliver G/0000-0002-8797-2667; Rambaut,
   Andrew/0000-0003-4337-3707; Faria, Nuno R/0000-0001-8839-2798; Levin,
   Anna S/0000-0003-2427-8368; Arias, Carlos/0000-0003-3130-4501; Esteban,
   Munoz Medina Jose/0000-0002-1289-4457; da-Costa, Antonio
   Charlys/0000-0001-5516-5177; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Bezerrra, Joao/0000-0002-9978-628X;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Segurado, Aluisio
   C/0000-0002-6311-8036; Wallau, Gabriel Luz/0000-0002-1419-5713; Marques,
   Ernesto T. A/0000-0003-3826-9358; Theze, Julien/0000-0001-8188-9494;
   Vinhal Frutuoso, Livia Carla/0000-0001-7926-1075; Grubaugh,
   Nathan/0000-0003-2031-1933; Loman, Nicholas/0000-0002-9843-8988;
   Raghwani, Jayna/0000-0001-8538-4995; Loose, Matthew/0000-0002-5264-0929;
   Holmes, Edward/0000-0001-9596-3552; Wu, Chieh-Hsi/0000-0001-9386-725X;
   Black, Allison/0000-0002-6618-4127; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Hill, Sarah/0000-0002-2995-2596; Giovanetti,
   Marta/0000-0002-5849-7326; Alcantara, Luiz/0000-0002-6769-9931
FU MRC/Wellcome Trust/Newton Fund Zika Rapid Response grant
   [MC_PC_15100/ZK/16-078]; USAID Emerging Pandemic Threats Program-2
   PREDICT-2United States Agency for International Development (USAID)
   [AID-OAA-A-14-00102]; MRC Bioinformatics Fellowship; Sir Henry Dale
   Fellowship [204311/Z/16/Z]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [457480/2014-9, 302584/2015-3,
   439975/2016-6]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2012/03417-7]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R35 GM119774,
   R01 HL105704]; NSFNational Science Foundation (NSF) [DGE-1256082];
   Abbott Laboratories, Inc.Abbott Laboratories; National Health and
   Medical Research CouncilNational Health and Medical Research Council of
   Australia [GNT1037231]; MRCMedical Research Council UK (MRC); CRUKCancer
   Research UK [ANR00310]; Wellcome TrustWellcome Trust; Royal SocietyRoyal
   Society of London [101237/Z/13/Z]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN, 278433-PREDEMICS]; EUEuropean Union (EU)
   [643476-COMPARE, 734548-ZIKAlliance]; IDAMS; DENFREE; DengueTools;
   PPSUSFACEPE [APQ-0302-4.01/13]; FACEPE [APQ-0044.2.11/16,
   APQ-0055.2.11/16]; German Ministry of Health; NATIONAL HEART, LUNG, AND
   BLOOD INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R01HL105704, R01HL105704, R01HL105704,
   R01HL105704, R01HL105704, R01HL105704, R01HL105704, R01HL105704,
   R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI120977, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   R33AI120977, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, R33AI120977, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, R21AI120977,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R35GM119774,
   R35GM119774, R35GM119774, R35GM119774, R35GM119774] Funding Source: NIH
   RePORTER; Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_15100, MR/L015080/1, MR/M501621/1] Funding Source: researchfish
FX We thank Fundacao Oswaldo Cruz in Bahia and Pernambuco states,
   University of Sao Paulo, Instituto Evandro Chagas, and the Brazilian
   Zika virus surveillance network for their essential contributions. We
   thank the following for giving us permission to use their unpublished
   genomes available on GenBank: R. Lanciotti, J. Lednicky, A. Enfissi, F.
   Baldanti, R. Shabman, B. Picket, R. Schinazi, M. Bonaldo, M. Gale, M.
   Capobianchi and C. Concetta, M. Leguia, J. Alberto Diaz, E.
   Sevilla-Reyes, A. Franz, M. GarciaBlanco and M. J. van Hemert. We thank
   P. Fernando da Costa Vasconcelos, S. Guerreiro Rodrigues, J. Cardoso, J.
   Vasconcelos, J. Vianez Jr, J. Gil Melgaco, J. Blumel, M. C. Brito
   Lobato, L. Nunes Fava, C. Ayres, L. Abade and F. Campos. L. C. J. A.
   thanks QIAGEN for reagents and equipment and M. R. T. N. thanks FERPEL
   for consumables. We thank Oxford Nanopore for technical support,
   particularly R. Dokos, Z. McDougall, S. Cowan, G. Sanghera, and O.
   Hartwell. This work was supported by an MRC/Wellcome Trust/Newton Fund
   Zika Rapid Response grant (MC_PC_15100/ZK/16-078) and by the USAID
   Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement
   AID-OAA-A-14-00102). N. J. L. is supported by an MRC Bioinformatics
   Fellowship. N. R. F. is funded by a Sir Henry Dale Fellowship (grant
   204311/Z/16/Z). CNPq contributed to trip expenses (grant 457480/2014-9).
   A.C.d.C. was supported by FAPESP # 2012/03417-7 and M. R. T. N. by CNPq
   grant no. 302584/2015-3. A. B. and T. B. were supported by NIH award R35
   GM119774. A. B. is supported by the NSF Graduate Research Fellowship
   Program (grant DGE-1256082). T. B. is a Pew Biomedical Scholar. C.Y.C.
   is partially supported by NIH grant R01 HL105704 and an award from
   Abbott Laboratories, Inc. E. C. H. is supported by a National Health and
   Medical Research Council Australia Fellowship (GNT1037231). C.- H. W. is
   supported by the MRC and CRUK (ANR00310) and by the Wellcome Trust and
   Royal Society (grant 101237/Z/13/Z). S. C. H. is supported by the
   Wellcome Trust. This research received funding from the ERC under grant
   agreements 614725-PATHPHYLODYN and 278433-PREDEMICS, and from EU Horizon
   2020 under agreements 643476-COMPARE and 734548-ZIKAlliance. T. J. and
   E. T. M. acknowledge funding from IDAMS, DENFREE, DengueTools, and
   PPSUSFACEPE (project APQ-0302-4.01/13). R. F. F. received funding from
   FACEPE (APQ-0044.2.11/16 and APQ-0055.2.11/16) and from CNPq
   (439975/2016-6). S. A. B. was supported by the Sicherheit von Blut und
   Geweben hinsichtlich der Abwesenheit von Zikaviren from the German
   Ministry of Health.
CR [Anonymous], 2014, R LANG ENV COMP
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   De Maio N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005421
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grubaugh N. D., 2017, NATURE
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Metsky HC, 2017, NATURE
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Ministerio da Saade, 2017, B EP SECR VIG SAUD
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Pacheco O., 2016, NEW ENGL J MED
   PAHO/WHO, 2016, PAHO WHO ZIK EP UPD
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Quick J., 2017, NAT PROTOCOLS
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schierup MH, 2000, GENETICS, V156, P879
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 226
Z9 230
U1 7
U2 81
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 406
EP +
DI 10.1038/nature22401
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900035
PM 28538727
OA Green Accepted, Green Published
DA 2020-12-09
ER

PT J
AU Vinhaes, ES
   Santos, LA
   Dias, L
   Andrade, NA
   Bezerra, VH
   de Carvalho, AT
   de Moraes, L
   Henriques, DF
   Azar, SR
   Vasilakis, N
   Ko, AI
   Andrade, BB
   Siqueira, IC
   Khouri, R
   Boaventura, VS
AF Vinhaes, Eriko S.
   Santos, Luciane A.
   Dias, Lislane
   Andrade, Nilvano A.
   Bezerra, Victor H.
   de Carvalho, Anderson T.
   de Moraes, Laise
   Henriques, Daniele F.
   Azar, Sasha R.
   Vasilakis, Nikos
   Ko, Albert I.
   Andrade, Bruno B.
   Siqueira, Isadora C.
   Khouri, Ricardo
   Boaventura, Viviane S.
TI Transient Hearing Loss in Adults Associated With Zika Virus Infection
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; sensorineural hearing loss; tinnitus; dizziness
ID BRAZIL
AB In 2015, during the outbreak of Zika virus (ZIKV) in Brazil, we identified 3 cases of acute hearing loss after exanthematous illness. Serology yielded finding compatible with ZIKV as the cause of a confirmed (n = 1) and a probable (n = 2) flavivirus infection, indicating an association between ZIKV infection and transient hearing loss.
C1 [Vinhaes, Eriko S.; Dias, Lislane; Andrade, Nilvano A.; Bezerra, Victor H.; de Carvalho, Anderson T.; Boaventura, Viviane S.] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Santos, Luciane A.; de Moraes, Laise; Ko, Albert I.; Andrade, Bruno B.; Siqueira, Isadora C.; Khouri, Ricardo; Boaventura, Viviane S.] Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz MS, Salvador, BA, Brazil.
   [Henriques, Daniele F.] World Hlth Org, Inst Evandro Chagas, Collaborating Ctr Reference & Res Arbovirus, Fundacao Nacl Sa,Minist Saude, Belem, Para, Brazil.
   [Azar, Sasha R.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Pathol, Galveston, TX USA.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Andrade, Bruno B.] Jose Silveira Fdn, Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil.
   [Khouri, Ricardo] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Boaventura, Viviane S.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
RP Boaventura, VS (corresponding author), Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM viviane.boaventura@bahia.fiocruz.br
RI Ko, Albert Icksang/P-2343-2015; Vasilakis, Nikos/ABE-7318-2020; Khouri,
   Ricardo/M-3184-2018; Boaventura, Viviane S/H-9165-2015; Andrade,
   Bruno/AAI-2248-2020; de Moraes, Laise Eduarda Paixao/N-4475-2017; de
   Siqueira, Isadora Cristina/R-9953-2016
OI Ko, Albert Icksang/0000-0001-9023-2339; Khouri,
   Ricardo/0000-0001-5664-4436; de Moraes, Laise Eduarda
   Paixao/0000-0001-9095-5860; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Andrade, Bruno/0000-0001-6833-3811
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1 R01 AI121207, R24
   AI120942]; "Programa Ciencias sem fronteiras," Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico of Brazil; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R24AI120942, R01AI121207, R24AI120942, R24AI120942,
   R01AI121207, R24AI120942, R24AI120942, R01AI121207, R01AI121207] Funding
   Source: NIH RePORTER
FX This work was supported by the National Institutes of Health (grant
   numbers 1 R01 AI121207 and R24 AI120942). R. K. and L. A. S. were
   supported by "Programa Ciencias sem fronteiras," Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico of Brazil.
CR Casetta I, 2011, J NEUROL, V258, P1880, DOI 10.1007/s00415-011-6011-3
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Ribeiro BNF, 2015, INT J SURG CASE REP, V8, P38, DOI 10.1016/j.ijscr.2014.10.057
   Greco A, 2011, AUTOIMMUN REV, V10, P756, DOI 10.1016/j.autrev.2011.05.005
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7
   Taki M, 2009, AURIS NASUS LARYNX, V36, P345, DOI 10.1016/j.anl.2008.05.016
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 15
Z9 15
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2017
VL 64
IS 5
BP 675
EP 677
DI 10.1093/cid/ciw770
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP3TA
UT WOS:000397303400020
PM 27927858
OA Green Published, Other Gold
DA 2020-12-09
ER

PT J
AU Oliveira, JV
   Pessoa, L
   Magalhaes, C
   Lima, JG
   Carvalho, DA
   Xavier, TC
   Pellegrini, R
   Bessa, G
   Figueiredo, EM
   Calgano, JI
   Romero, F
   dos Santos, D
   Oliveira, A
   Silva, P
   Giovanetti, M
   Goes, J
   Lima, B
   Carneiro, MW
   Duarte, A
   Lima, FW
   Alcantara, LC
   de Siqueira, IC
AF Oliveira, Joao V.
   Pessoa, Lorena
   Magalhaes, Claudio
   Lima, Jessica G.
   Carvalho, Daniel A.
   Xavier, Tereza C.
   Pellegrini, Rosana
   Bessa, Gloryane
   Figueiredo, Eduardo M.
   Calgano, Juan I.
   Romero, Fernando
   dos Santos, Daiana
   Oliveira, Aline
   Silva, Paloma
   Giovanetti, Marta
   Goes, Jaqueline
   Lima, Breno
   Carneiro, Marcia W.
   Duarte, Alan
   Lima, Fernanda W.
   Alcantara, Luiz C.
   de Siqueira, Isadora C.
TI PREVALENCE OF PREVIOUS AND RECENT INFECTIONS BY ZIKA VIRUS, DENGUE VIRUS
   AND CHIKUNGUNYA VIRUS IN PREGNANT WOMEN AND SURVEILLANCE FOR CONGENITAL
   ZIKA INFECTIONS IN SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Oliveira, Joao V.; Pessoa, Lorena; Magalhaes, Claudio; Lima, Jessica G.; Carvalho, Daniel A.; dos Santos, Daiana; Oliveira, Aline; Silva, Paloma; Giovanetti, Marta; Goes, Jaqueline; Lima, Breno; Carneiro, Marcia W.; Alcantara, Luiz C.; de Siqueira, Isadora C.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Xavier, Tereza C.; Pellegrini, Rosana; Bessa, Gloryane; Figueiredo, Eduardo M.; Calgano, Juan I.; Romero, Fernando] Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   [Duarte, Alan; Lima, Fernanda W.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; amsalu, ribka/G-8780-2019;
   Giovanetti, Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1426
BP 443
EP 443
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204142
DA 2020-12-09
ER

PT J
AU do Rosario, MS
   de Jesus, PAP
   Vasilakis, N
   Farias, DS
   Novaes, MAC
   Rodrigues, SG
   Martins, LC
   Vasconcelos, PFD
   Ko, AI
   Alcantara, LCJ
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Vasilakis, Nikos
   Farias, Daniel Santana
   Caires Novaes, Marco Antonio
   Rodrigues, Sueli Guerreiro
   Martins, Livia Caricio
   da Costa Vasconcelos, Pedro Fernando
   Ko, Albert Icksang
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Case Report: Guillain-Barre Syndrome after Zika Virus Infection in
   Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DENGUE; OUTBREAK; BAHIA
AB Zika virus (ZIKV) is an emerging flavivirus, which has caused a widespread outbreak in the Americas. Shortly after its introduction in 2015, a cluster of cases with Guillain Barre syndrome was detected in Brazil. Herein, we describe two cases from the city of Salvador, who developed ascending paresis after an acute exanthematous illness. The patients were admitted to the intensive care unit with tetraparesis and cranial nerve palsy, which resolved after intravenous administration of human immunoglobulin. Serological evaluation detected IgM-specific ZIKV antibodies. In regions of Zika virus transmission, health-care workers must be aware of the potential severe neurological complications associated with ZIKV infection and be prepared to provide prompt diagnosis, treatment, and supportive care.
C1 [do Rosario, Mateus Santana; Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Biodefense & Emerging Infect Dis, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Caires Novaes, Marco Antonio] Fundacao Monte Tabor, Hosp Salo Rafael, Salvador, BA, Brazil.
   [Rodrigues, Sueli Guerreiro; Martins, Livia Caricio; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas SVS MS, Secao Arbovirol & Febres Hemorrag, Ananindeua, Brazil.
   [Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas, Salvador, BA, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Caires Novaes, Marco Antonio] Hosp Sao Rafael, Fundacao Monte Tabor, Salvador, BA, Brazil.
   [Martins, Livia Caricio; da Costa Vasconcelos, Pedro Fernando] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Belem, Para, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Gongalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI Vasconcelos, Pedro/AAH-3142-2019; Vasilakis, Nikos/ABE-7318-2020; Ko,
   Albert Icksang/P-2343-2015; de Siqueira, Isadora Cristina/R-9953-2016
OI Ko, Albert Icksang/0000-0001-9023-2339; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Jesus, Pedro Antonio/0000-0003-1211-2272;
   do Rosario, Mateus/0000-0001-7404-6392; Alcantara,
   Luiz/0000-0002-6769-9931
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504, R01TW009504, R01TW009504, R01TW009504, R01TW009504]
   Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R24AI120942, R01AI121207,
   R24AI120942, R01AI121207, R24AI120942, R24AI120942, R24AI120942,
   R24AI120942] Funding Source: NIH RePORTER
FX We are grateful to Marcia Weber for the laboratorial technical
   assistance, Fernanda Washington de M. Lima and Daniel Moura for
   assistance in the serological diagnosis, and the physicians and nurses
   involved in the patient's clinical treatment. We also thank Bruno B.
   Andrade for the critical review of the manuscript. This work was
   supported in part by the NIH grant R24AI120942 to Nikos Vasilakis.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos GS, 2015, JPN J INFECT DIS, V68, P45, DOI 10.7883/yoken.JJID.2014.063
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   DVIS/CIEVS, 2015, INF EP DOENC EX MAT
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 53
Z9 53
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 1157
EP 1160
DI 10.4269/ajtmh.16-0306
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600035
PM 27645785
OA Green Published, Bronze
DA 2020-12-09
ER

PT J
AU Giovanetti, M
   Faria, NR
   Nunes, MRT
   de Vasconcelos, JM
   Lourenco, J
   Rodrigues, SG
   Vianez, JL
   da Silva, SP
   Lemos, PS
   Tavares, FN
   Martin, DP
   do Rosario, MS
   Siqueira, IC
   Ciccozzi, M
   Pybus, OG
   de Oliveira, T
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Teixeira Nunes, Marcio Roberto
   de Vasconcelos, Janaina Mota
   Lourenco, Jose
   Rodrigues, Sueli Guerreiro
   Vianez, Joao Lidio, Jr.
   da Silva, Sandro Patroca
   Lemos, Poliana Silva
   Tavares, Fernando Neto
   Martin, Darren Patrick
   do Rosario, Mateus Santana
   Siqueira, Isadora Cristina
   Ciccozzi, Massimo
   Pybus, Oliver G.
   de Oliveira, Tulio
   Alcantara Junior, Luiz Carlos
TI Zika virus complete genome from Salvador, Bahia, Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Full-length sequence; Phylogeny
AB In May 2015 the first autochthonous Zika virus infection was reported in Brazil. Rapid and urgent measures are needed to contain the ongoing outbreak. Here we report the full-length ZIKV coding sequence from Bahia. Genetic analysis of outbreak sequences will be essential for characterizing the diversity of circulating strains, identifying hotspots of virus transmission and guiding public health control. Rapid and urgent measures are needed to contain the ongoing outbreak. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Giovanetti, Marta; do Rosario, Mateus Santana; Siqueira, Isadora Cristina; Alcantara Junior, Luiz Carlos] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   [Teixeira Nunes, Marcio Roberto; de Vasconcelos, Janaina Mota; Rodrigues, Sueli Guerreiro; Vianez, Joao Lidio, Jr.; Lemos, Poliana Silva; Tavares, Fernando Neto] Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Martin, Darren Patrick] Univ Cape Town, Fac Hlth Sci, Div Computat Biol, ZA-7925 Cape Town, South Africa.
   [do Rosario, Mateus Santana] Hosp Santa Isabel, Salvador, BA, Brazil.
   [Ciccozzi, Massimo] Natl Inst Hlth, Rome, Italy.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr, Durban, South Africa.
RP Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, BR-42296710 Salvador, BA, Brazil.
EM giovanetti.marta@gmail.com
RI Faria, Nuno R/I-2975-2012; de Siqueira, Isadora Cristina/R-9953-2016;
   Giovanetti, Marta/AAK-7408-2020; CICCOZZI, MASSIMO/C-6484-2016; Pybus,
   Oliver G/B-2640-2012; Vianez Junior, Joao Lidio/I-9547-2016
OI Faria, Nuno R/0000-0001-8839-2798; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; CICCOZZI, MASSIMO/0000-0003-3866-9239;
   Pybus, Oliver G/0000-0002-8797-2667; Giovanetti,
   Marta/0000-0002-5849-7326; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441; Alcantara, Luiz/0000-0002-6769-9931; do
   Rosario, Mateus/0000-0001-7404-6392; Lourenco, Jose/0000-0002-9318-2581
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O., 2014, PLOS NEGLECT TROP D, V9, P8
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grard G, 2014, PLOS NEGLECT TROP D, P8
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, N ENGL J MED
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Rodrigues Faria N., 2016, PLOS CURR OUTBREAKS
   Ventura C. V., 2016, LANCET, V16
   Zamree I, 2005, Trop Biomed, V22, P217
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 17
Z9 17
U1 0
U2 112
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2016
VL 41
BP 142
EP 145
DI 10.1016/j.meegid.2016.03.030
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DL5BU
UT WOS:000375652800020
PM 27071531
OA Green Published
DA 2020-12-09
ER

PT J
AU Costa, F
   Sarno, M
   Khouri, R
   Freitas, BD
   Siqueira, I
   Ribeiro, GS
   Ribeiro, HC
   Campos, GS
   Alcantara, LC
   Reis, MG
   Weaver, SC
   Vasilakis, N
   Ko, AI
   Almeida, AR
AF Costa, Federico
   Sarno, Manoel
   Khouri, Ricardo
   Freitas, Bruno de Paula
   Siqueira, Isadora
   Ribeiro, Guilherme S.
   Ribeiro, Hugo C.
   Campos, Gubio S.
   Alcantara, Luiz C.
   Reis, Mitermayer G.
   Weaver, Scott C.
   Vasilakis, Nikos
   Ko, Albert I.
   Almeida, Antonio Raimundo
TI Emergence of Congenital Zika Syndrome: Viewpoint From the Front Lines
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID VIRUS; DENGUE
C1 [Khouri, Ricardo; Ribeiro, Guilherme S.; Alcantara, Luiz C.] Minist Saude, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Freitas, Bruno de Paula; Ribeiro, Hugo C.] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Ave Paulo 6,2240,Apt 1004, BR-41810001 Salvador, BA, Brazil.
   Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
   [Costa, Federico] Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
   [Sarno, Manoel] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia & Maternidade Clime, Rua Limoeiro 137, BR-41055150 Salvador, BA, Brazil.
   [Siqueira, Isadora; Reis, Mitermayer G.] Funda, Ctr Pesquisas Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Campos, Gubio S.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Almeida, Antonio Raimundo] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia, Ave Santa Luzia 149-302,Ed Bosque Italia, BR-40295050 Salvador, BA, Brazil.
RP Costa, F (corresponding author), Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
EM fcosta2001@gmail.com
RI Vasilakis, Nikos/ABE-7318-2020; Ko, Albert Icksang/P-2343-2015; Costa,
   Federico/G-1838-2015; Khouri, Ricardo/M-3184-2018; Ribeiro,
   Guilherme/B-6624-2008; de Siqueira, Isadora Cristina/R-9953-2016;
   Weaver, Scott C/D-6490-2011; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; Khouri, Ricardo/0000-0001-5664-4436;
   Ribeiro, Guilherme/0000-0002-6798-2059; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Weaver, Scott C/0000-0001-8016-8556; Reis,
   Mitermayer/0000-0002-3051-9060; Alcantara, Luiz/0000-0002-6769-9931
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207, R01AI121207]
   Funding Source: NIH RePORTER; FIC NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01 TW009504] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI121207] Funding Source:
   Medline
CR Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 9
TC 50
Z9 52
U1 0
U2 15
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAY 17
PY 2016
VL 164
IS 10
BP 689
EP +
DI 10.7326/M16-0332
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL8GF
UT WOS:000375878500019
PM 26914810
OA Green Published, Green Accepted
DA 2020-12-09
ER

PT J
AU Lima, CM
   Santos, S
   Dourado, A
   Carvalho, NB
   Bittencourt, V
   Lessa, MM
   Siqueira, I
   Carvalho, E
AF Lima, Clara Monica
   Santos, Silvane
   Dourado, Adriana
   Carvalho, Natalia B.
   Bittencourt, Valeria
   Lessa, Marcus Miranda
   Siqueira, Isadora
   Carvalho, EdgarM.
TI Association of Sicca Syndrome with Proviral Load and Proinflammatory
   Cytokines in HTLV-1 Infection
SO JOURNAL OF IMMUNOLOGY RESEARCH
LA English
DT Article
ID VIRUS TYPE-I; LABIAL SALIVARY-GLANDS; SJOGRENS-SYNDROME; TAX GENE;
   CEREBROSPINAL-FLUID; HIGH PREVALENCE; HAM/TSP; MYELOPATHY; EXPRESSION;
   ARTHRITIS
AB The Sjogren syndrome has been diagnosed in patients with HTLV-1 associated myelopathy and dry mouth and dry eyes are documented in HTLV-1 carriers. However the diagnosis of Sjogren syndrome in these subjects has been contested. In this cross-sectional study, we evaluated the role of immunological factors and proviral load, in sicca syndrome associated with HTLV-1 in patients without myelopathy. Subjects were recruited in the HTLV-1 Clinic, from 2009 to 2011. The proviral load and cytokine levels (IFN-gamma, TNF-alpha, IL-5, and IL-10) were obtained from a database containing the values presented by the subjects at admission in the clinic. Of the 272 participants, 59 (21.7%) had sicca syndrome and in all of them anti-Sjogren syndrome related antigen A (SSA) and antigen B (SSB) were negatives. The production of TNF-alpha and IFN-gamma was higher in the group with sicca syndrome (P < 0.05) than in HTLV-1 infected subjects without sicca syndrome. Our data indicates that patients with sicca syndrome associated with HTLV-1 do not have Sjogren syndrome. However the increased production of TNF-alpha and IFN-gamma in this group of patients may contribute to the pathogenesis of sicca syndrome associated with HTLV-1.
C1 [Lima, Clara Monica; Lessa, Marcus Miranda; Carvalho, EdgarM.] Univ Fed Bahia, Sch Med, Postgrad Program Hlth Sci, BR-40025010 Salvador, BA, Brazil.
   [Lima, Clara Monica; Santos, Silvane; Dourado, Adriana; Carvalho, Natalia B.; Bittencourt, Valeria; Siqueira, Isadora; Carvalho, EdgarM.] Univ Fed Bahia, Prof Edgard Santos Univ Hosp, Serv Immunol, BR-40110060 Salvador, BA, Brazil.
   [Lima, Clara Monica; Lessa, Marcus Miranda] Univ Fed Bahia, Dept Otolaryngol, BR-40110060 Salvador, BA, Brazil.
   [Santos, Silvane; Carvalho, EdgarM.] Natl Inst Sci & Technol Trop Dis CNPq MCT, BR-40110060 Salvador, BA, Brazil.
   [Santos, Silvane] State Univ Feira de Santana UEFS, Dept Biol Sci, BR-44036900 Feira De Santana, BA, Brazil.
   [Siqueira, Isadora; Carvalho, EdgarM.] Oswaldo Cruz Fdn FIOCRUZ, Goncalo Moniz Res Ctr, BR-40296710 Salvador, BA, Brazil.
RP Carvalho, E (corresponding author), Univ Fed Bahia, Sch Med, Postgrad Program Hlth Sci, BR-40025010 Salvador, BA, Brazil.; Carvalho, E (corresponding author), Univ Fed Bahia, Prof Edgard Santos Univ Hosp, Serv Immunol, BR-40110060 Salvador, BA, Brazil.; Carvalho, E (corresponding author), Natl Inst Sci & Technol Trop Dis CNPq MCT, BR-40110060 Salvador, BA, Brazil.; Carvalho, E (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Goncalo Moniz Res Ctr, BR-40296710 Salvador, BA, Brazil.
EM imuno@ufba.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Carvalho, Natalia/H-3977-2015
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Carvalho,
   Natalia/0000-0003-2586-7877
CR BAILER RT, 1994, J RHEUMATOL, V21, P2217
   Blomberg S, 2000, SCAND J IMMUNOL, V51, P612
   Cartier L, 2005, REV MED CHILE, V133, P1183, DOI 10.4067/S0034-98872005001000007
   CARTIER L, 1995, J NEUROL NEUROSUR PS, V58, P244, DOI 10.1136/jnnp.58.2.244
   Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001
   Carvalho Mônica Martinelli Nunes de, 2006, Rev. Bras. Reumatol., V46, P334, DOI 10.1590/S0482-50042006000500006
   Carvalho Mônica Martinelli Nunes de, 2006, Rev. Bras. Reumatol., V46, P315, DOI 10.1590/S0482-50042006000500003
   Caskey MF, 2007, AIDS RES HUM RETROV, V23, P365, DOI 10.1089/aid.2006.0140
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   Ferraz-Chaoui AK, 2010, RHEUMATOL INT, V30, P775, DOI 10.1007/s00296-009-1066-5
   Garlet GP, 2010, CLIN INFECT DIS, V50, pE11, DOI 10.1086/649871
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   Giozza SP, 2008, REV STOMATOL CHIR, V109, P153, DOI 10.1016/j.stomax.2007.08.008
   GREEN JE, 1989, NATURE, V341, P72, DOI 10.1038/341072a0
   Guerreiro JB, 2006, CLIN EXP IMMUNOL, V145, P296, DOI 10.1111/j.1365-2249.2006.03150.x
   IJICHI S, 1990, ANN RHEUM DIS, V49, P718, DOI 10.1136/ard.49.9.718
   KOHLER PF, 1985, ARTHRITIS RHEUM-US, V28, P1128, DOI 10.1002/art.1780281008
   KURODA Y, 1993, J NEUROIMMUNOL, V45, P133, DOI 10.1016/0165-5728(93)90173-V
   MADDISON PJ, 1985, CLIN EXP IMMUNOL, V62, P337
   Mariette X, 2000, CLIN EXP RHEUMATOL, V18, P341
   MARIETTE X, 1993, ARTHRITIS RHEUM-US, V36, P1423, DOI 10.1002/art.1780361015
   MORGAN OS, 1989, LANCET, V2, P1184
   Motokawa S, 1996, ANN RHEUM DIS, V55, P193, DOI 10.1136/ard.55.3.193
   Murphy EL, 2004, EMERG INFECT DIS, V10, P109, DOI 10.3201/eid1001.020714
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Nakamura H, 1997, ANN RHEUM DIS, V56, P167, DOI 10.1136/ard.56.3.167
   Nascimento MCF, 2009, CLIN EXP IMMUNOL, V156, P455, DOI 10.1111/j.1365-2249.2008.03869.x
   NISHIMOTO N, 1990, J NEUROL SCI, V97, P183, DOI 10.1016/0022-510X(90)90217-B
   Nishiura Y, 1996, TOHOKU J EXP MED, V179, P227, DOI 10.1620/tjem.179.227
   Olindo S, 2005, J NEUROL SCI, V237, P53, DOI 10.1016/j.jns.2005.05.010
   PINHEIRO SRAA, 1995, ARQ NEURO-PSIQUIAT, V53, P777, DOI 10.1590/S0004-282X1995000500011
   Poetker SKW, 2011, J CLIN VIROL, V51, P54, DOI 10.1016/j.jcv.2011.02.004
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Grassi MFR, 2011, J MED VIROL, V83, P1269, DOI 10.1002/jmv.22087
   Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7
   Santos SB, 2012, J MED VIROL, V84, P1809, DOI 10.1002/jmv.23341
   SUMIDA T, 1994, ARTHRITIS RHEUM, V37, P545, DOI 10.1002/art.1780370415
   VERNANT JC, 1988, LANCET, V1, P177
   Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475
NR 39
TC 8
Z9 9
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-8861
EI 2314-7156
J9 J IMMUNOL RES
JI J Immunol. Res.
PY 2016
VL 2016
AR 8402059
DI 10.1155/2016/8402059
PG 6
WC Immunology
SC Immunology
GA DC5MR
UT WOS:000369265600001
PM 26904697
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Bastos, MDS
   Neves, Y
   Carvalho, N
   Souza, A
   Neto, A
   Siqueira, I
   Santos, S
   Carvalho, EM
AF Santana Bastos, Maria de Lourdes
   Neves, Yuri
   Carvalho, Natalia
   Souza, Anselmo
   Neto, Abraao
   Siqueira, Isadora
   Santos, Silvane
   Carvalho, Edgar M.
TI Consequences of the association between HTLV-1 and tuberculosis
SO RETROVIROLOGY
LA English
DT Meeting Abstract
C1 [Santana Bastos, Maria de Lourdes; Neves, Yuri; Carvalho, Natalia; Souza, Anselmo; Neto, Abraao; Santos, Silvane; Carvalho, Edgar M.] Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.
   [Siqueira, Isadora; Carvalho, Edgar M.] Fiocruz MS, Ctr Pesquisa Goncalo Muniz, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4690
J9 RETROVIROLOGY
JI Retrovirology
PD AUG 28
PY 2015
VL 12
SU 1
MA P77
DI 10.1186/1742-4690-12-S1-P77
PG 2
WC Virology
SC Virology
GA DA0EC
UT WOS:000367468500118
OA DOAJ Gold, Green Accepted
DA 2020-12-09
ER

PT J
AU Tanajura, D
   Neto, A
   Siqueira, I
   Gusmao, V
   Oliveira, P
   Giozza, S
   Castro, N
   Carvalho, N
   Santos, S
   Carvalho, EM
AF Tanajura, Davi
   Neto, Abraao
   Siqueira, Isadora
   Gusmao, Valeria
   Oliveira, Paulo
   Giozza, Silvana
   Castro, Neviton
   Carvalho, Natalia
   Santos, Silvane
   Carvalho, Edgar M.
TI The clinical spectrum of HTLV-1 infection
SO RETROVIROLOGY
LA English
DT Meeting Abstract
C1 [Tanajura, Davi; Neto, Abraao; Gusmao, Valeria; Oliveira, Paulo; Giozza, Silvana; Castro, Neviton; Carvalho, Natalia; Santos, Silvane; Carvalho, Edgar M.] Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.
   [Siqueira, Isadora; Carvalho, Edgar M.] Ctr Pesquisa Goncalo Muniz FIOCRUZ, Salvador, BA, Brazil.
   [Carvalho, Edgar M.] Fac Med Bahia UFBA, Salvador, BA, Brazil.
EM imuno@ufba.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 1
Z9 1
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4690
J9 RETROVIROLOGY
JI Retrovirology
PD AUG 28
PY 2015
VL 12
SU 1
MA O19
DI 10.1186/1742-4690-12-S1-O19
PG 1
WC Virology
SC Virology
GA DA0EC
UT WOS:000367468500019
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Santos, SB
   Oliveira, P
   Luna, T
   Souza, A
   Nascimento, M
   Siqueira, I
   Tanajura, D
   Muniz, AL
   Glesby, MJ
   Carvalho, EM
AF Santos, Silvane Braga
   Oliveira, Paulo
   Luna, Tania
   Souza, Anselmo
   Nascimento, Marcia
   Siqueira, Isadora
   Tanajura, Davi
   Muniz, Andre Luiz
   Glesby, Marshall J.
   Carvalho, Edgar M.
TI Immunological and viral features in patients with overactive bladder
   associated with human T-cell lymphotropic virus type 1 infection
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HTLV-1; immune response; cytokines; chemokines; proviral load
ID MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; I-ASSOCIATED MYELOPATHY; HTLV-1
   PROVIRAL LOAD; ASYMPTOMATIC CARRIERS; DIAGNOSTIC-CRITERIA;
   PERIPHERAL-BLOOD; URINARY SYMPTOMS; HAM/TSP PATIENTS; UP-REGULATION;
   MANIFESTATIONS
AB The majority of patients infected with human T-cell lymphotropic virus-type 1 (HTLV-1) are considered carriers, but a high frequency of urinary symptoms of overactive bladder, common in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) have been documented in these patients. The aim of this study was to determine if immunological and viral factors that are seen in HAM/TSP are also observed in these patients. Participants were classified as HTLV-1 carriers (n?=?45), HTLV-1 patients suffering from overactive bladder (n?=?45) and HAM/TSP (n?=?45). Cells from HTLV-1 overactive bladder patients produced spontaneously more proinflammatory cytokines than carriers. TNF-a and IL-17 levels were similar in HAM/TSP and HTLV-1 overactive bladder patients. High proviral load was found in patients with overactive bladder and HAM/TSP and correlated with proinflammatory cytokines. In contrast with findings in patients with HAM/TSP, serum levels of Th1 chemokines were similar in HTLV-1 overactive bladder and carriers. Exogenous addition of regulatory cytokines decreased spontaneous IFN-? production in cell cultures from HTLV-1 overactive bladder patients. The results show that HTLV-1 overactive bladder and HAM/TSP patients have in common some immunological features as well as similar proviral load profile. The data show that HTLV-1 overactive bladder patients are still able to down regulate their inflammatory immune response. In addition, these patients express levels of chemokines similar to carriers, which may explain why they have yet to develop the same degree of spinal cord damage as seen in patients with HAM/TSP. These patients present symptoms of overactive bladder, which may be an early sign of HAM/TSP. J. Med. Virol. 84:18091817, 2012. (c) 2012 Wiley Periodicals, Inc.
C1 [Santos, Silvane Braga; Oliveira, Paulo; Luna, Tania; Souza, Anselmo; Nascimento, Marcia; Siqueira, Isadora; Tanajura, Davi; Muniz, Andre Luiz; Carvalho, Edgar M.] Univ Fed Bahia, Serv Immunol, Prof Edgard Santos Univ Hosp, Salvador, BA, Brazil.
   [Santos, Silvane Braga; Souza, Anselmo; Tanajura, Davi; Muniz, Andre Luiz; Carvalho, Edgar M.] Natl Inst Sci & Technol Trop Dis CNPq MCT, Salvador, BA, Brazil.
   [Glesby, Marshall J.] Weill Cornell Med Coll, New York, NY USA.
RP Carvalho, EM (corresponding author), Univ Fed Bahia UFBA, Serv Imunol, Complexo Hosp Univ Prof Edgard Santos, Rua Joao das Botas S-N, BR-40110160 Canela, BA, Brazil.
EM imuno@ufba.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Souza, Anselmo/D-3570-2014
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Tanajura Costa,
   Davi/0000-0002-4583-2391
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI079238, K24
   AI078884]; Brazilian National Research Council (CNPq)National Council
   for Scientific and Technological Development (CNPq); NATIONAL INSTITUTE
   OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI079238,
   R01AI079238, K24AI078884, R01AI079238, K24AI078884, K24AI078884,
   K24AI078884, K24AI078884, R01AI079238] Funding Source: NIH RePORTER
FX Grant sponsor: National Institute of Health; Grant numbers: AI079238;
   K24 AI078884; Grant sponsor: Brazilian National Research Council (CNPq).
CR Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704
   Abrams Paul, 2009, Neurourol Urodyn, V28, P287, DOI 10.1002/nau.20737
   Araujo AQC, 1998, J ACQ IMMUN DEF SYND, V19, P536, DOI 10.1097/00042560-199812150-00014
   Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451
   Biddison WE, 1997, J IMMUNOL, V159, P2018
   Furtado MDBS, 2012, J MED VIROL, V84, P664, DOI 10.1002/jmv.23227
   Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001
   Caskey MF, 2007, AIDS RES HUM RETROV, V23, P365, DOI 10.1089/aid.2006.0140
   Castro NM, 2007, UROLOGY, V69, P813, DOI 10.1016/j.urology.2007.01.052
   De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   Dodon MD, 2004, J GEN VIROL, V85, P1921, DOI 10.1099/vir.0.79921-0
   Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295
   Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X
   Garlet GP, 2010, CLIN INFECT DIS, V50, pE11, DOI 10.1086/649871
   Giozza SP, 2008, REV STOMATOL CHIR, V109, P153, DOI 10.1016/j.stomax.2007.08.008
   Goto H, 1997, IMMUNOBIOLOGY, V197, P513, DOI 10.1016/S0171-2985(97)80083-6
   Guerreiro JB, 2006, CLIN EXP IMMUNOL, V145, P296, DOI 10.1111/j.1365-2249.2006.03150.x
   Hollsberg P, 1999, MICROBIOL MOL BIOL R, V63, P308
   Izumo S, 1996, NEUROLOGY, V46, P1016, DOI 10.1212/WNL.46.4.1016
   Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Matsuzaki T, 2001, J NEUROVIROL, V7, P228
   Nagai M, 2003, J NEUROVIROL, V9, P228, DOI 10.1080/13550280390194028
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Nagai M, 2001, J INFECT DIS, V183, P197, DOI 10.1086/317932
   Nakamura H, 2009, RHEUMATOLOGY, V48, P854, DOI 10.1093/rheumatology/kep072
   Narikawa K, 2005, J NEUROIMMUNOL, V159, P177, DOI 10.1016/j.jneuroim.2004.10.011
   Nishiura Y, 1996, TOHOKU J EXP MED, V179, P227, DOI 10.1620/tjem.179.227
   Olindo S, 2005, J NEUROL SCI, V237, P53, DOI 10.1016/j.jns.2005.05.010
   Oliveira P, 2007, CLINICS, V62, P191, DOI 10.1590/S1807-59322007000200015
   Oliveira P, 2010, UROLOGY, V75, P1100, DOI 10.1016/j.urology.2009.11.041
   Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004
   Primo J, 2009, BRAZ J MED BIOL RES, V42, P761, DOI 10.1590/S0100-879X2009005000008
   Grassi MFR, 2011, J MED VIROL, V83, P1269, DOI 10.1002/jmv.22087
   Rocha PN, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-15
   Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7
   Santos SB, 2006, NEUROIMMUNOMODULAT, V13, P145, DOI 10.1159/000097259
   Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679
   Tikkinen KAO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000195
   Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15
NR 41
TC 18
Z9 18
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD NOV
PY 2012
VL 84
IS 11
BP 1809
EP 1817
DI 10.1002/jmv.23341
PG 9
WC Virology
SC Virology
GA 010AM
UT WOS:000309066800015
PM 22997085
OA Green Accepted
DA 2020-12-09
ER

PT J
AU Costa, DT
   dos Santos, ALMA
   de Castro, NM
   de Siqueira, IC
   de Carvalho, EM
   Glesby, MJ
AF Costa, Davi Tanajura
   Muniz Alves dos Santos, Andre Luiz
   de Castro, Neviton Matos
   de Siqueira, Isadora Cristina
   de Carvalho Filho, Edgar Marcelino
   Glesby, Marshall Jay
TI Neurological symptoms and signs in HTLV-1 patients with overactive
   bladder syndrome
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE spinal cord diseases; urinary bladder neurogenic; tropical spastic
   paraparesis; myelitis
ID MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; I PROVIRAL LOAD; VIRUS TYPE-I;
   INFECTED INDIVIDUALS; HAM/TSP; URINARY; MANIFESTATIONS; ABNORMALITIES;
   DISABILITY; CARRIERS
AB Objective: To compare neurological symptoms and signs in HTLV-1 asymptomatic carriers and HTLV-1 patients with overactive bladder (OB) syndrome. Methods: We studied 102 HTLV-1 positive individuals without HAM/TSP (HTLV-1 associated myelopathy/tropical spastic paraparesis) divided into two groups according to the presence or absence of OB syndrome. Clinical interview, neurological exam and proviral load was performed in all patients. Results and conclusions: Individuals with OB were more commonly female (84.3 vs. 60.8% of asymptomatics, p=0.01). The prevalence of neurological complaints was higher in OB group, especially hand or foot numbness and arm or leg weakness. There was no difference between the groups in neurological strength and reflexes. Weakness complaint remained strongly associated with OB in multivariate logistic regression analysis adjusting for sex and age [adjusted odds ratio and 95%CI 3.59 (1.45-8.88) in arms and 6.68 (2.63-16.93) in legs]. Proviral toad was also different between the two groups with higher level on OB individuals.
C1 [Costa, Davi Tanajura; Muniz Alves dos Santos, Andre Luiz; de Castro, Neviton Matos; de Siqueira, Isadora Cristina; de Carvalho Filho, Edgar Marcelino] Bahia Fed Univ UFBA, Dept Immunol, Salvador, BA, Brazil.
   [Glesby, Marshall Jay] Weill Cornell Med Coll, New York, NY USA.
RP Costa, DT (corresponding author), Hosp Univ Prof Edgard Santos, Serv Imunol, Rua Augusto Viana S-N,5 Andar, BR-40110060 Salvador, BA, Brazil.
EM davi81@me.com
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Tanajura Costa,
   Davi/0000-0002-4583-2391
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI079238-02, R01 079238, K24
   AI078884]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [K24AI078884, R01AI079238, R01AI079238, K24AI078884,
   R01AI079238, K24AI078884, K24AI078884, R01AI079238, K24AI078884] Funding
   Source: NIH RePORTER
FX Dr. Carvalho is funded by NIH grants R01 AI079238-02.; Dr. Glesby is
   fund by NIH grants R01 079238 and K24 AI078884.
CR Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
   Araujo AQC, 2009, ARQ NEURO-PSIQUIAT, V67, P132, DOI 10.1590/S0004-282X2009000100036
   Biswas HH, 2009, NEUROLOGY, V73, P781, DOI 10.1212/WNL.0b013e3181b6bba9
   Campbell WW, 2005, DEJONGS NEUROLOGIC E
   Caskey MF, 2007, AIDS RES HUM RETROV, V23, P365, DOI 10.1089/aid.2006.0140
   Castro Neviton M., 2007, Int. braz j urol., V33, P238, DOI 10.1590/S1677-55382007000200016
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   GESSAIN A, 1985, LANCET, V2, P407
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Leite ACC, 2004, J NEUROL, V251, P877, DOI 10.1007/s00415-004-0455-7
   Matsuzaki T, 2001, J NEUROVIROL, V7, P228
   Medical Research Council, 1976, 45 MED RES COUNC
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Nakagawa M, 1996, J NEUROVIROL, V2, P345, DOI 10.3109/13550289609146899
   Nakamura T, 2009, FOLIA NEUROPATHOL, V47, P182
   Oliveira P, 2007, CLINICS, V62, P191, DOI 10.1590/S1807-59322007000200015
   POIESZ BJ, 1981, NATURE, V294, P268, DOI 10.1038/294268a0
   Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472
   SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721
   Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679
   Zunt JR, 1999, NEUROLOGY, V53, P386, DOI 10.1212/WNL.53.2.386
NR 22
TC 6
Z9 6
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD APR
PY 2012
VL 70
IS 4
BP 252
EP 256
DI 10.1590/S0004-282X2012000400005
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 927EF
UT WOS:000302889200005
PM 22510736
OA DOAJ Gold, Green Accepted
DA 2020-12-09
ER

PT J
AU de Assis, TSM
   Braga, ASD
   Pedras, MJ
   Oliveira, E
   Barral, A
   de Siqueira, IC
   Costa, CHN
   Costa, DL
   Holanda, TA
   Soares, VYR
   Bia, M
   Caldas, ADM
   Romero, GAS
   Rabello, A
AF de Assis, Talia S. M.
   Braga, Alexandre S. da C.
   Pedras, Mariana J.
   Oliveira, Edward
   Barral, Aldina
   de Siqueira, Isadora C.
   Costa, Carlos H. N.
   Costa, Dorcas L.
   Holanda, Thiago A.
   Soares, Vitor Y. R.
   Bia, Mauro
   Caldas, Arlene de J. M.
   Romero, Gustavo A. S.
   Rabello, Ana
TI Multi-centric prospective evaluation of rk39 rapid test and direct
   agglutination test for the diagnosis of visceral leishmaniasis in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE direct agglutination test; rapid test rK39; visceral leishmaniasis;
   sensitivity; specificity and diagnostic accuracy
ID STRIP TEST; ANTIGEN; PERFORMANCE; DIPSTICK; ACCURACY; AZAR
AB The diagnosis of visceral leishmaniasis (VL) is still a major problem in Brazil and several other countries where the disease is endemic. The use of an easy-to-use and interpret, sensitive, and specific method that requires no complex infrastructure or specialized professionals, such as direct agglutination test (DAT) and the rK39-based rapid immunochromatographic test may enhance the diagnosis of disease. This study evaluated the performance of a rapid test (DiaMed- IT-LEISH (R)) and the DAT for the diagnosis of VL in 213 parasitologically confirmed cases and 119 controls with clinical suspicion of VL and confirmation of another etiology. The sensitivities and specificities of the rapid test were 93% and 97%, respectively and those of the DAT were 90% and 96%, respectively. The positive predictive values of the rapid test and the DAT were 98% and 97%, respectively and the negative predictive values were 89% and 84%, respectively. The Kappa index showed agreement between both methods classified as substantial (0.77). This study showed that the DAT and the rapid test can be used to diagnose VL in Brazil, following a pilot study for implementation of the rapid test in the health services. (C) 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [de Assis, Talia S. M.; Braga, Alexandre S. da C.; Pedras, Mariana J.; Oliveira, Edward; Rabello, Ana] Fundacao Oswaldo Cruz FIOCRUZ, CPqRR, Lab Pesquisas Clin, Belo Horizonte, MG, Brazil.
   [Barral, Aldina; de Siqueira, Isadora C.] Fiocruz MS, CPqGM, Salvador, BA, Brazil.
   [de Siqueira, Isadora C.] Hosp Crianca Obras Sociais Irma Dulce, Salvador, BA, Brazil.
   [Costa, Carlos H. N.; Costa, Dorcas L.; Holanda, Thiago A.; Soares, Vitor Y. R.; Bia, Mauro] Univ Fed Piaui, Teresina, Piaui, Brazil.
   [Caldas, Arlene de J. M.] Univ Fed Maranhao, Sao Luis, Maranhao, Brazil.
   [Romero, Gustavo A. S.] Univ Brasilia, Brasilia, DF, Brazil.
RP Rabello, A (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, CPqRR, Lab Pesquisas Clin, Belo Horizonte, MG, Brazil.
EM ana@cpqrr.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Barral, Aldina/B-4191-2009;
   Romero, Gustavo A.S./F-7214-2012
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Barral,
   Aldina/0000-0002-7177-464X; Romero, Gustavo A.S./0000-0003-1425-926X
FU Secretary of Health Surveillance; Brazilian Ministry of Health; CNPq
   (National Counsel of Technological and Scientific Development)National
   Council for Scientific and Technological Development (CNPq); Oswaldo
   Cruz Foundation - FIOCRUZ
FX Secretary of Health Surveillance, Brazilian Ministry of Health, CNPq
   (National Counsel of Technological and Scientific Development) and
   Oswaldo Cruz Foundation - FIOCRUZ.
CR ASSIS TSM, 2008, EPIDEMIOL SERV SATID, V17, P105
   Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003
   Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Carvalho SFG, 2003, AM J TROP MED HYG, V68, P321
   Chappuis F, 2003, TROP MED INT HEALTH, V8, P277, DOI 10.1046/j.1365-3156.2003.01026.x
   Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005
   Chappuis F, 2006, BMJ-BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Neto VA, 2009, INT J INFECT DIS, V13, P182, DOI 10.1016/j.ijid.2008.06.003
   Oliveira E, 2009, T ROY SOC TROP MED H, V103, P1279, DOI 10.1016/j.trstmh.2009.04.007
   Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76
   Sharma U, 2009, INDIAN J EXP BIOL, V47, P412
   Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X
   Sundar S, 2007, TROP MED INT HEALTH, V12, P284, DOI 10.1111/j.1356-3156.2006.01775.x
   Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x
NR 18
TC 33
Z9 33
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD FEB
PY 2011
VL 105
IS 2
BP 81
EP 85
DI 10.1016/j.trstmh.2010.09.004
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 722MY
UT WOS:000287437600004
PM 20970152
OA Green Published
DA 2020-12-09
ER

PT J
AU de Oliveira, MDP
   Vieira, MD
   Primo, J
   Siqueira, IC
   Carvalho, EM
   Farre, L
   Fatal, PL
   Bittencourt, AL
AF Paim de Oliveira, Maria de Fatima
   Vieira, Maria das Gracas
   Primo, Janeusa
   Siqueira, Isadora C.
   Carvalho, Edgar M.
   Farre, Lourdes
   Fatal, Priscila Lima
   Bittencourt, Achilea L.
TI Flower cells in patients with infective dermatitis associated with
   HTLV-1
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE HTLV-1 infection; Infective dermatitis associated with HTLV-1; Adult
   T-cell leukemia/lymphoma; Flower cells; Skin diseases caused by HTLV-1
ID MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; I PROVIRAL DNA; ABNORMAL
   LYMPHOCYTES; LEUKEMIA-LYMPHOMA; VIRUS; LEUKEMIA/LYMPHOMA; ATL; CHILDREN;
   FEATURES; CARRIERS
AB Background: Infective dermatitis associated with HTLV-1 (IDH) is a severe childhood form of eczema that may progress to adult T-cell leukemia/lymphoma (ATL).
   Objective: In this study, the presence of clinical and laboratory parameters suggestive of ATL was evaluated in a cohort of 30 patients with IDH.
   Study design: Over a period of 33 months, the patients were submitted to three-monthly clinical evaluations, routine laboratory exams, full blood count and blood smears, and to six-monthly blood sampling for HTLV-1 proviral load determination. HTLV-1 proviral load was quantified using real-time TaqMan PCR assay.
   Results: Abnormal cells (Ably) were found in the peripheral blood smears of nine patients (30%), flower cells being detected in five of these cases (16.6%). The presence of Ably and flower cells was not associated with a higher proviral load in those patients.
   Conclusions: This is the first report on the presence of flower cells in HTLV-1-infected children and adolescents. Furthermore, these cells have not previously been reported in IDH patients. The cases with flower cells probably represent precursory ATL cases, these patients being at a greater risk of developing ATL. (C) 2010 Elsevier B. V. All rights reserved.
C1 [Paim de Oliveira, Maria de Fatima; Fatal, Priscila Lima] Univ Fed Bahia, Prof Edgar Santos Teaching Hosp, Dept Dermatol, BR-40110060 Salvador, BA, Brazil.
   [Vieira, Maria das Gracas; Bittencourt, Achilea L.] Univ Fed Bahia, Prof Edgar Santos Teaching Hosp, Dept Pathol, BR-40110060 Salvador, BA, Brazil.
   [Primo, Janeusa] Univ Fed Bahia, Prof Edgar Santos Teaching Hosp, Dept Internal Med, BR-40110060 Salvador, BA, Brazil.
   [Siqueira, Isadora C.; Carvalho, Edgar M.] Univ Fed Bahia, Prof Edgar Santos Teaching Hosp, Immunol Lab, BR-40110060 Salvador, BA, Brazil.
   [Farre, Lourdes] Fundacao Oswaldo Cruz, Goncalo Muniz Res Ctr, Lab Expt Pathol, Salvador, BA, Brazil.
RP Bittencourt, AL (corresponding author), Univ Fed Bahia, Lab Patol, Complexo Hosp Univ Prof Edgard Santos, Rua Dr Augusto Viana S-N Canela, BR-40110060 Salvador, BA, Brazil.
EM achilea@uol.com.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Farre,
   Lourdes/0000-0002-3168-1940
FU National Research Council (CNPq)National Council for Scientific and
   Technological Development (CNPq); Bahia State Foundation for the Support
   of Research (FAPESB)
FX This study was supported by the National Research Council (CNPq) and the
   Bahia State Foundation for the Support of Research (FAPESB). ALB and EMC
   are senior CNPq investigators. The authors are grateful to Dr. Vitoria
   Regina Rego, head of the Dermatology Clinic at the Federal University of
   Bahia, who permitted access to the clinic facilities.
CR Bittencourt AL, 2007, AM J CLIN PATHOL, V128, P875, DOI 10.1309/2YGD1P0QCVCWBLDX
   Bittencourt A, 2009, ACTA ONCOL, V48, P598, DOI 10.1080/02841860802657235
   Bittencourt Achiléa Lisboa, 2006, J. Pediatr. (Rio J.), V82, P411, DOI 10.1590/S0021-75572006000800004
   Brites C, 2005, CLIN INFECT DIS, V40, P90
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   Farre L, 2008, CLIN INFECT DIS, V46, P440, DOI 10.1086/524695
   Hisada M, 1998, INT J CANCER, V77, P188, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;188::AID-IJC3&gt;3.0.CO;2-M
   KINOSHITA K, 1985, BLOOD, V66, P120
   La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439
   Maloney EM, 2004, J INFECT DIS, V189, P41, DOI 10.1086/380567
   Primo J, 2009, BRAZ J MED BIOL RES, V42, P761, DOI 10.1590/S0100-879X2009005000008
   Primo JRL, 2005, CLIN INFECT DIS, V41, P535, DOI 10.1086/432058
   Sacher RA, 1999, BRIT J HAEMATOL, V105, P758, DOI 10.1046/j.1365-2141.1999.01408.x
   SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x
   TACHIBANA N, 1992, INT J CANCER, V51, P593, DOI 10.1002/ijc.2910510415
   Tsukasaki K, 1999, BRIT J HAEMATOL, V105, P369, DOI 10.1111/j.1365-2141.1999.01323.x
   YAMAGUCHI K, 1988, BRIT J HAEMATOL, V68, P169, DOI 10.1111/j.1365-2141.1988.tb06185.x
   YEE DL, 2008, HOFFMAN HEMATOLOGY B, P2432
NR 18
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
J9 J CLIN VIROL
JI J. Clin. Virol.
PD AUG
PY 2010
VL 48
IS 4
BP 288
EP 290
DI 10.1016/j.jcv.2010.05.005
PG 3
WC Virology
SC Virology
GA 625LZ
UT WOS:000279898100014
PM 20541459
DA 2020-12-09
ER

PT J
AU Chagas, JRLP
   Nascimento, MCF
   Bittencourt, ACL
   Carvalho, EM
   Siqueira, IC
   Valve, LF
   Oliveira, MFSP
AF Chagas, J. R. L. P.
   Nascimento, M. C. F.
   Bittencourt, A. C. L.
   Carvalho, E. M.
   Siqueira, I. C.
   Valve, L. F.
   Oliveira, M. F. S. P.
TI High HTLV-1 Proviral Loads a Marker for HTLV-1 Associated
   Myelopathy/Tropical Spastic Paraparesis is also Detected in Patients
   with Infective Dermatitis Associated with HTLV-1
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
C1 [Chagas, J. R. L. P.; Nascimento, M. C. F.; Bittencourt, A. C. L.; Carvalho, E. M.; Siqueira, I. C.; Valve, L. F.; Oliveira, M. F. S. P.] Univ Fed Bahia, BR-41170290 Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1254
EP 1254
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200154
DA 2020-12-09
ER

PT J
AU Siqueira, IC
   Muniz, AL
   Carvalho, EM
   Orge, G
   Santos, MT
   Oliveira, P
   Giozza, S
   Bittencourt, VG
AF Siqueira, I. C.
   Muniz, A. L.
   Carvalho, E. M.
   Orge, G.
   Santos, M. T.
   Oliveira, P.
   Giozza, S.
   Bittencourt, V. G.
TI Clinical Manifestations in a Large Group of HTLV-1 Infected Patients in
   Northeastern Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1257
EP 1258
PG 2
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200163
DA 2020-12-09
ER

PT J
AU Siqueira, IC
   Muniz, AL
   Carvalho, EM
   Siqueira, I
   Oliveira, P
AF Siqueira, I. C.
   Muniz, A. L.
   Carvalho, E. M.
   Siqueira, I
   Oliveira, P.
TI HTLV-I-Associated Myelopathy Manifested after Renal Transplantation
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1260
EP 1260
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200169
DA 2020-12-09
ER

PT J
AU Santos, SMB
   Muniz, AL
   Carvalho, EM
   Siqueira, I
   Nascimento, M
   Oliveira, P
   Luna, T
AF Santos, S. M. B.
   Muniz, A. L.
   Carvalho, E. M.
   Siqueira, I
   Nascimento, M.
   Oliveira, P.
   Luna, T.
TI Immune Response Influence the Disease Expression Associated with HTLV-1
   Infection
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
C1 [Santos, S. M. B.; Muniz, A. L.; Carvalho, E. M.; Siqueira, I; Nascimento, M.; Oliveira, P.; Luna, T.] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, BR-41170290 Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1263
EP 1263
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200177
DA 2020-12-09
ER

PT J
AU Primo, J
   Siqueira, I
   Nascimento, MCF
   Oliveira, MF
   Farre, L
   Carvalho, EM
   Bittencourt, AL
AF Primo, J.
   Siqueira, I.
   Nascimento, M. C. F.
   Oliveira, M. F.
   Farre, L.
   Carvalho, E. M.
   Bittencourt, A. L.
TI High HTLV-1 proviral load, a marker for HTLV-1-associated
   myelopathy/tropical spastic paraparesis, is also detected in patients
   with infective dermatitis associated with HTLV-1
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Infective dermatitis associated with HTLV-1; HTLV-1-associated
   myelopathy/tropical spastic paraparesis; HTLV-1 proviral loads
ID VIRUS TYPE-I; T-CELL LEUKEMIA; CHILDHOOD; CARRIERS; CHILDREN
AB Salvador (BA, Brazil) is an endemic area for human T-cell lymphotrophic virus type 1 (HTLV-1). The overall prevalence of HTLV-1 infection in the general population has been estimated to be 1.76%. HTLV-1 carriers may develop a variety of diseases such as adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH). IDH is a chronic and severe form of childhood exudative and infective dermatitis involving mainly the scalp, neck and ears. It has recently been observed that 30% of patients with IDH develop juvenile HAM/TSP. The replication of HTLV-1 has been reported to be greater in adult HAM/TSP patients than in asymptomatic HTLV-1 carriers. In the current study, the proviral load of 28 children and adolescents with IDH not associated with HAM/TSP was determined and the results were compared to those obtained in 28 HTLV-1 adult carriers and 28 adult patients with HAM/TSP. The proviral load in IDH patients was similar to that of patients with HAM/TSP and much higher than that found in HTLV-1 carriers. The high levels of proviral load in IDH patients were not associated with age, duration of illness, duration of breast-feeding, or activity status of the skin disease. Since proviral load is associated with neurological disability, these data support the view that IDH patients are at high risk of developing HAM/TSP.
C1 [Bittencourt, A. L.] Univ Fed Bahia, Complexo Hosp Univ Prof Edgard Santos, Serv Anat Patol, Dept Patol, BR-40110160 Salvador, BA, Brazil.
   [Primo, J.; Oliveira, M. F.] Univ Fed Bahia, Complexo Hosp Univ Prof Edgard Santos, Dept Med Interna, BR-40110160 Salvador, BA, Brazil.
   [Siqueira, I.; Nascimento, M. C. F.; Carvalho, E. M.] Univ Fed Bahia, Complexo Hosp Univ Prof Edgard Santos, Lab Imunol, BR-40110160 Salvador, BA, Brazil.
   [Farre, L.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Muniz, Lab Patol Expt, Salvador, BA, Brazil.
RP Bittencourt, AL (corresponding author), Univ Fed Bahia, Complexo Hosp Univ Prof Edgard Santos, Serv Anat Patol, Dept Patol, Rua Augusto Viana S-N, BR-40110160 Salvador, BA, Brazil.
EM achilea@uol.com.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Farre,
   Lourdes/0000-0002-3168-1940
FU Conselho Nacional de Pesquisa (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado da Bahia (FAPESB); NIH/Fogarty International CenterUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43 TW007127]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW007127, D43TW007127, D43TW007127,
   D43TW007127, D43TW007127, D43TW007127] Funding Source: NIH RePORTER
FX Research supported by Conselho Nacional de Pesquisa (CNPq), Fundacao de
   Amparo a Pesquisa do Estado da Bahia (FAPESB), and NIH/Fogarty
   International Center grant D43 TW007127.
CR Bangham CRM, 1999, PHILOS T ROY SOC B, V354, P691, DOI 10.1098/rstb.1999.0422
   de Oliveira MDFSP, 2005, CLIN INFECT DIS, V40, pE90, DOI 10.1086/430064
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Farre L, 2008, CLIN INFECT DIS, V46, P440, DOI 10.1086/524695
   Gabet AS, 2000, ONCOGENE, V19, P4954, DOI 10.1038/sj.onc.1203870
   HANCHARD B, 1991, LANCET, V338, P1593, DOI 10.1016/0140-6736(91)92413-V
   La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439
   Maloney EM, 2006, J INFECT DIS, V194, P552, DOI 10.1086/506365
   Maloney EM, 2004, J INFECT DIS, V189, P41, DOI 10.1086/380567
   Maloney EM, 2000, PEDIATR INFECT DIS J, V19, P560, DOI 10.1097/00006454-200006000-00014
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Primo JRL, 2005, CLIN INFECT DIS, V41, P535, DOI 10.1086/432058
NR 13
TC 29
Z9 29
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD AUG
PY 2009
VL 42
IS 8
BP 761
EP 764
DI 10.1590/S0100-879X2009005000008
PG 4
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 485LI
UT WOS:000269123000012
PM 19578703
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-09
ER

PT J
AU Nascimento, MCF
   Primo, J
   Bittencourt, A
   Siqueira, I
   Oliveira, MD
   Meyer, R
   Schriefer, A
   Santos, SB
   Carvalho, EM
AF Nascimento, M. C. F.
   Primo, J.
   Bittencourt, A.
   Siqueira, I.
   Oliveira, M. de Fatima
   Meyer, R.
   Schriefer, A.
   Santos, S. B.
   Carvalho, E. M.
TI Infective dermatitis has similar immunological features to human T
   lymphotropic virus-type 1-associated myelopathy/tropical spastic
   paraparesis
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Article
DE cytokines; interleukins; dermatological infections; HTLV-I; II
ID I PROVIRAL LOAD; HTLV-I; CELL LEUKEMIA; HAM/TSP; CARRIERS; DISABILITY;
   EXPRESSION; CHEMOKINES; CHILDHOOD; RESPONSES
AB Human T lymphotropic virus-type 1 (HTLV-1) is the causal agent of the HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), adult T cell leukaemia/lymphoma and infective dermatitis associated with HTLV-1 (IDH). Over-production of proinflammatory cytokines and an increase in HTLV-1 proviral load are features of HAM/TSP, but the immunological basis of IDH has not been established. In addition to severe cutaneous manifestations, the importance of IDH relies on the observation that up to 30% of children with IDH develop HAM/TSP in childhood and adolescence. In this study we determined the immune response in patients with IDH measuring interleukin (IL)-4, IL-5, IL-10, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha levels as well as the HTLV-1 proviral load. Additionally, regulatory cytokines and anti-cytokines were added to cultures to evaluate the ability of these molecules to down-modulate TNF-alpha and IFN-gamma synthesis. HTLV-1 carriers and patients with HAM/TSP served as controls. TNF-alpha and IFN-gamma levels were higher in IDH than in HTLV-1 carriers. There was no difference in IFN-gamma and TNF-alpha concentrations in IDH and HAM/TSP patients. There was a tendency for higher IL-4 mRNA expression and immunoglobulin E (IgE) levels in IDH than in HTLV-1 carriers, but the difference did not reach statistical significance. The HTLV-1 proviral load was significantly higher in IDH patients than in HTLV-1 carriers. IDH is characterized by an exaggerated Th1 immune response and high HTLV-1 proviral load. The similarities between the immunological response in patients with IDH and HAM/TSP and the high proviral load observed in IDH provide support that IDH is a risk factor for development of HAM/TSP.
C1 [Nascimento, M. C. F.; Siqueira, I.; Schriefer, A.; Santos, S. B.; Carvalho, E. M.] Univ Fed Bahia, Serv Imunol, Hosp Univ Prof Edgard Santos, BR-40110160 Salvador, BA, Brazil.
   [Primo, J.; Bittencourt, A.; Oliveira, M. de Fatima] Univ Fed Bahia, Dept Patol, Hosp Univ Prof Edgard Santos, BR-40110160 Salvador, BA, Brazil.
   [Meyer, R.] Univ Fed Bahia, Inst Ciencias Saude, Lab Imunol, Salvador, BA, Brazil.
   [Santos, S. B.] Univ Estadual Feira de Santana, Dept Ciencias Biol, Feira De Santana, BA, Brazil.
RP Carvalho, EM (corresponding author), Univ Fed Bahia, Serv Imunol, Hosp Univ Prof Edgard Santos, 5 Andar,Rua Joao das Botas S-N, BR-40110160 Salvador, BA, Brazil.
EM edgar@ufba.br
RI Schriefer, Albert/AAP-2765-2020; de Siqueira, Isadora
   Cristina/R-9953-2016
OI Schriefer, Albert/0000-0002-5496-6789; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099
FU NIH/Fogarty International CenterUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43 TW007127]; Fundacao de Amparo a Pesquisa
   do Estado da Bahia (FAPESB); Brazilian National Research Council
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); FOGARTY INTERNATIONAL CENTERUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW007127, D43TW007127, D43TW007127,
   D43TW007127, D43TW007127, D43TW007127] Funding Source: NIH RePORTER
FX This study was supported by NIH/Fogarty International Center grant D43
   TW007127, Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) and
   Brazilian National Research Council (CNPq). EMC and ALB are senior
   investigators of the CNPq. We acknowledge Dr AurElia Porto and Dr AndrE
   Muniz in providing medical assistance, Dr Carlos Brites for the
   performance of serological testing and the secretarial assistance of
   Elbe Silva in the preparation of this manuscript. We also thank Roberto
   Novoa for reviewing the manuscript and editing the English.
CR Akdis M, 1999, J IMMUNOL, V163, P466
   Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886
   Araujo MIAS, 2004, J INFECT DIS, V190, P1797, DOI 10.1086/425017
   BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290
   Biddison WE, 1997, J IMMUNOL, V159, P2018
   Bittencourt AL, 2005, EUR J DERMATOL, V15, P26
   BLANK A, 1995, LANCET, V346, P710, DOI 10.1016/S0140-6736(95)92326-8
   BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293
   Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001
   Clyti E, 2004, ANN DERMATOL VENER, V131, P191, DOI 10.1016/S0151-9638(04)93569-7
   de Oliveira MDFSP, 2005, CLIN INFECT DIS, V40, pE90, DOI 10.1086/430064
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   GESSAIN A, 1985, LANCET, V2, P407
   Guerreiro JB, 2006, CLIN EXP IMMUNOL, V145, P296, DOI 10.1111/j.1365-2249.2006.03150.x
   HANCHARD B, 1991, LANCET, V338, P1593, DOI 10.1016/0140-6736(91)92413-V
   HANIFIN JM, 2003, DERMATOL NURS S, V15, P6
   Hofer MF, 1999, J INVEST DERMATOL, V112, P171, DOI 10.1046/j.1523-1747.1999.00492.x
   Izumo S, 1996, NEUROLOGY, V46, P1016, DOI 10.1212/WNL.46.4.1016
   JACOBSON S, 1990, ANN NEUROL, V27, P149, DOI 10.1002/ana.410270209
   KIRA J, 1991, ANN NEUROL, V29, P194, DOI 10.1002/ana.410290214
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439
   Lessa HA, 2001, AM J TROP MED HYG, V65, P87, DOI 10.4269/ajtmh.2001.65.87
   LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x
   Mahe A, 2004, BRIT J DERMATOL, V150, P958, DOI 10.1111/j.1365-2133.2004.05834.x
   Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602
   Matsuzaki T, 2001, J NEUROVIROL, V7, P228
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Nagai M, 2001, ANN NEUROL, V50, P807, DOI 10.1002/ana.10065
   Nagai M, 2001, J INFECT DIS, V183, P197, DOI 10.1086/317932
   Nobre V, 2006, CLIN INFECT DIS, V43, P1257, DOI 10.1086/508177
   Primo JRL, 2005, CLIN INFECT DIS, V41, P535, DOI 10.1086/432058
   PRINCE H, 1990, J ACQ IMMUN DEF SYND, V3, P1199
   Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7
   Santos SB, 2006, NEUROIMMUNOMODULAT, V13, P145, DOI 10.1159/000097259
   TENDLER CL, 1990, P NATL ACAD SCI USA, V87, P5218, DOI 10.1073/pnas.87.13.5218
   Tschachler E, 1998, ARCH DERMATOL, V134, P487, DOI 10.1001/archderm.134.4.487
   UMEHARA F, 1994, J NEUROPATH EXP NEUR, V53, P72, DOI 10.1097/00005072-199401000-00009
   WALSHE MM, 1967, BRIT J DERMATOL, V79, P229, DOI 10.1111/j.1365-2133.1967.tb11479.x
NR 40
TC 30
Z9 30
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD JUN
PY 2009
VL 156
IS 3
BP 455
EP 462
DI 10.1111/j.1365-2249.2008.03869.x
PG 8
WC Immunology
SC Immunology
GA 443AU
UT WOS:000265883400011
PM 19438598
OA Green Published
DA 2020-12-09
ER

PT J
AU Ferraroni, N
   Crovella, S
   Guimaraes, RL
   Brandao, LAC
   Constantino-Silva, RN
   Alves, C
   Siqueira, I
   Loja, C
   Duarte, AJS
   Grumach, AS
AF Ferraroni, N.
   Crovella, S.
   Guimaraes, R. L.
   Brandao, L. A. C.
   Constantino-Silva, R. N.
   Alves, C.
   Siqueira, I.
   Loja, C.
   Duarte, A. J. S.
   Grumach, A. S.
TI Polymorphisms of Mannose Binding Lectin gene (MBL2) in Brazilian blood
   donors (n=300)
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Academy-of-Allergy-Asthma-and-Immunology
CY MAR 13-17, 2009
CL Washington, DC
SP Amer Acad Allergy, Asthma & Immunol
C1 [Ferraroni, N.; Constantino-Silva, R. N.; Alves, C.; Duarte, A. J. S.; Grumach, A. S.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Crovella, S.] IRCCS Burlo Garofolo, Trieste, Italy.
   [Crovella, S.; Guimaraes, R. L.; Brandao, L. A. C.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Siqueira, I.; Loja, C.] Hosp Serv Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RI da Silva, Rosemeire Navickas Constantino/Y-1427-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0091-6749
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD FEB
PY 2009
VL 123
IS 2
MA 631
BP S165
EP S165
DI 10.1016/j.jaci.2008.12.621
PG 1
WC Allergy; Immunology
SC Allergy; Immunology
GA 410RR
UT WOS:000263596301104
DA 2020-12-09
ER

PT J
AU Porto, A
   Santos, SB
   Siqueira, I
   Muniz, AL
   Carvalho, EM
AF Porto, Aurelia
   Santos, Silvane B.
   Siqueira, Isadora
   Muniz, Andre Luiz
   Carvalho, Edgar M.
TI A COHORT STUDY EVALUATING IMMUNOLOGICAL AND CLINICAL CONSEQUENCES OF THE
   CO-INFECTION HTLV-1 AND SCHISTOSOMA MANSONI
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Porto, Aurelia; Santos, Silvane B.; Siqueira, Isadora; Muniz, Andre Luiz; Carvalho, Edgar M.] Univ Fed Bahia, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
MA 784
BP 231
EP 231
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644601149
DA 2020-12-09
ER

PT J
AU Morgan, DJ
   Caskey, MF
   Abbehusen, C
   Oliveira-Filho, J
   Araujo, C
   Porto, AF
   Santos, SB
   Orge, GO
   Joia, MJ
   Muniz, AL
   Siqueira, I
   Glesby, MJ
   Carvalho, E
AF Morgan, Daniel J.
   Caskey, Marina F.
   Abbehusen, Cristiane
   Oliveira-Filho, Jamary
   Araujo, Cesar
   Porto, Aurelia F.
   Santos, Silvane Braga
   Orge, Gloria O.
   Joia, Maria Jose
   Muniz, Andre L.
   Siqueira, Isadora
   Glesby, Marshall J.
   Carvalho, Edgar
TI Brain magnetic resonance Imaging white matter lesions are frequent in
   HTLV-I carriers and do not discriminate from HAM/TSP
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID TROPICAL SPASTIC PARAPARESIS; MULTIPLE-SCLEROSIS; CLINICAL-FEATURES;
   PROVIRAL LOAD; MYELOPATHY; MRI; INFECTION; LEUKOENCEPHALOPATHY; BRAZIL;
   BAHIA
AB Human T lymphotropic virus (HTLV)-I is known to cause HTLV-1-associated myelopathy/tropical spastic paraparesis (HAMITSP) and other pronounced disease in less than 4% of those infected. However, evidence is accumulating that a proportion of HTLV-I carriers have neurological and urological symptoms without fulfilling criteria for HAM/TSP. Brain white matter (WM) lesions on magnetic resonance imaging (MRI) are frequently seen in HAM/TSP. HTLV-I carriers with MRI scans for other neurological diagnoses have WM lesions more frequently than expected. We studied 10 patients with HAMITSP and 20 HTLV-I carriers without overt neurological disease and evaluated clinical characteristics, viral load, total, small, large, confluent WM lesion number, and lesion volume on MRI. Cerebral WM lesions were found in of 85% of HTLV-I carriers and 80% of HAMITSP patients. Lesion number, size or location was no different between carriers and HAM/TSP. Cognitive function was lower in HAM/TSP (p = 0.045) but did not correlate with WM lesion number. Viral load and peripheral blood mononuclear cell interferon-gamma production correlated positively (p = 0.001) but did not correlate with lesion number or volume. Conventional brain MRI frequently shows WM lesions in HTLY-I-infected individuals suggesting potential early central nervous system inflammation with rare development of progressive disease.
C1 [Oliveira-Filho, Jamary; Porto, Aurelia F.; Santos, Silvane Braga; Orge, Gloria O.; Joia, Maria Jose; Muniz, Andre L.; Siqueira, Isadora; Carvalho, Edgar] Univ Fed Bahia, Serv Immunol, Salvador, BA, Brazil.
   [Morgan, Daniel J.; Caskey, Marina F.; Glesby, Marshall J.] Cornell Univ, Weill Med Coll, Dept Int Med & Infect Dis, New York, NY 10021 USA.
   [Abbehusen, Cristiane; Araujo, Cesar] Image Mem Radiol Clin, Salvador, BA, Brazil.
RP Carvalho, E (corresponding author), Univ Fed Bahia, Serv Immunol, Salvador, BA, Brazil.
EM imuno@ufba.br
RI Oliveira-Filho, Jamary/B-6441-2016; de Siqueira, Isadora
   Cristina/R-9953-2016
OI Oliveira-Filho, Jamary/0000-0003-1915-0423; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Caskey, Marina/0000-0003-1727-8693
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1 R03-AI60830, T32-AI07613, R03 AI060830,
   R03 AI060830-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, R03AI060830,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, R03AI060830, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613] Funding
   Source: NIH RePORTER
CR ALCINDOR F, 1992, NEURORADIOLOGY, V35, P69
   AZEVEDO ES, 1982, HUM BIOL, V54, P329
   Bagnato F, 2005, J NEUROVIROL, V11, P525, DOI 10.1080/13550280500385039
   Caskey MF, 2007, AIDS RES HUM RETROV, V23, P365, DOI 10.1089/aid.2006.0140
   Castro N, 2005, INT J IMPOT RES, V17, P364, DOI 10.1038/sj.ijir.3901335
   Castro Neviton M., 2007, Int. braz j urol., V33, P238, DOI 10.1590/S1677-55382007000200016
   CASTRO NM, 2007, INT BRAZ J UROL, V33, P244
   De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   DETHE G, 1993, AIDS RES HUM RETROV, V9, P381, DOI 10.1089/aid.1993.9.381
   FAZEKAS F, 1989, EUR NEUROL, V29, P164, DOI 10.1159/000116401
   Ferraz AC, 1997, ARQ NEURO-PSIQUIAT, V55, P728, DOI 10.1590/S0004-282X1997000500008
   GESSAIN A, 1992, ANN INTERN MED, V117, P933, DOI 10.7326/0003-4819-117-11-933
   GODOY AJ, 1995, J NEUROL SCI, V133, P102, DOI 10.1016/0022-510X(95)00161-T
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   Howard AK, 2003, CAN J NEUROL SCI, V30, P41, DOI 10.1017/S0317167100002420
   KIRA J, 1988, J NEUROL SCI, V87, P221, DOI 10.1016/0022-510X(88)90247-X
   KIRA J, 1991, J NEUROL SCI, V106, P41, DOI 10.1016/0022-510X(91)90192-A
   KURODA Y, 1995, NEUROLOGY, V45, P30, DOI 10.1212/WNL.45.1.30
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   LAGRENADE L, 1990, LANCET, V336, P1345
   Melo A, 1994, Arq Neuropsiquiatr, V52, P320
   Milagres ACP, 2002, NEUROEPIDEMIOLOGY, V21, P153, DOI 10.1159/000054813
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Orland JR, 2003, NEUROLOGY, V61, P1588, DOI 10.1212/01.WNL.0000096011.92542.DA
   OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191
   RUDGE P, 1991, J NEUROL NEUROSUR PS, V54, P689, DOI 10.1136/jnnp.54.8.689
   Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7
   VICTOROFF J, 1994, NEUROLOGY, V44, P2267, DOI 10.1212/WNL.44.12.2267
   Zunt JR, 1999, NEUROLOGY, V53, P386, DOI 10.1212/WNL.53.2.386
NR 30
TC 29
Z9 29
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD DEC
PY 2007
VL 23
IS 12
BP 1499
EP 1503
DI 10.1089/aid.2007.0077
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 246PL
UT WOS:000252019200007
PM 18160007
OA Green Accepted
DA 2020-12-09
ER

PT J
AU Carvalho, EM
   Nascimento, MC
   Castro, N
   Muniz, ALA
   de Jesus, AR
   Porto, AF
   Siqueira, I
   Santos, SB
AF Carvalho, Edgar M.
   Nascimento, Marcia C.
   Castro, Neviton
   Muniz, Andre Luiz A.
   de Jesus, Amelia R.
   Porto, Aurelia F.
   Siqueira, Isadora
   Santos, Silvane B.
TI Immunological response and proviral load as factors influencing disease
   expression in HTLV-1
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [Carvalho, Edgar M.; Nascimento, Marcia C.; Castro, Neviton; Muniz, Andre Luiz A.; de Jesus, Amelia R.; Porto, Aurelia F.; Siqueira, Isadora; Santos, Silvane B.] Univ Fed Bahia, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 283
BP 80
EP 80
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758200282
DA 2020-12-09
ER

PT J
AU Moreira, ED
   De Siqueira, IC
   Alcantara, AP
   De Moura, CGG
   De Carvalho, WA
   Riley, L
AF Moreira, E. D., Jr.
   De Siqueira, I. C.
   Alcantara, A. P.
   De Moura, C. G. Guereiro
   De Carvalho, W. A.
   Riley, L.
TI Antimicrobial resistance of Escherichia coli strains causing
   community-acquired urinary tract infections among insured and uninsured
   Populations in a large urban center
SO JOURNAL OF CHEMOTHERAPY
LA English
DT Article
DE Escherichia coli; antimicrobial resistance; community-acquired; urinary
   tract infection; Brazil
ID SURVEILLANCE PROGRAM; UNITED-STATES; SUSCEPTIBILITY; PATHOGENS;
   HOSPITALS; WOMEN; FLUOROQUINOLONES; NITROFURANTOIN; CIPROFLOXACIN;
   UROPATHOGENS
AB We assessed the susceptibility of Escherichia coli strains causing community-acquired urinary tract infection (UTI) in a large urban center in Brazil, comparing two different populations (patients with health insurance vs. uninsured). 581 non-duplicate strains of E. coli were isolated. The prevalence of antimicrobial resistance was greater than 20% for ampicillin (51%), trimethoprim-sulfamethoxazole (43%), tetracycline (41%) and chloramphenicol (22%). Overall, 12% of the E. coli isolates were resistant to ciprofloxacin. Resistance prevalences to most antimicrobials were similar in the two study populations. Our data provide much needed information on the prevalence of antimicrobial resistance among E. coli causing community-acquired UTI in Brazil. Antimicrobial resistance among strains of E. coli causing community-acquired UTIs was relatively high, particularly resistance to ciprofloxacin.
C1 Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil.
   Assoc Obras Sociais Irma Dulce, BR-40420000 Salvador, BA, Brazil.
   Hosp Sao Rafael, Diretoria Cient, BR-41256900 Salvador, BA, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.
RP Moreira, ED (corresponding author), Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM edson@cpqgm.fiocruz.br
RI Moreira, Edson D/J-1758-2012; de Siqueira, Isadora Cristina/R-9953-2016;
   Moreira, Edson/W-7437-2019
OI Moreira, Edson D/0000-0002-7081-8348; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Moreira, Edson/0000-0002-7081-8348
CR Dyer IE, 1998, WESTERN J MED, V169, P265
   Farrell DJ, 2003, J INFECTION, V46, P94, DOI 10.1053/jinf.2002.1091
   Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7
   Gales AC, 2002, DIAGN MICR INFEC DIS, V44, P289, DOI 10.1016/S0732-8893(02)00470-4
   Garcia-Rodriguez JA, 1998, CHEMOTHERAPY, V44, P28, DOI 10.1159/000048461
   Goettsch W, 2000, J ANTIMICROB CHEMOTH, V46, P223, DOI 10.1093/jac/46.2.223
   Goldstein FW, 2000, EUR J CLIN MICROBIOL, V19, P112, DOI 10.1007/s100960050440
   Gupta K, 1999, INT J ANTIMICROB AG, V11, P305, DOI 10.1016/S0924-8579(99)00035-7
   Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880
   Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1
   Iqbal J, 1997, JPN J MED SCI BIOL, V50, P241, DOI 10.7883/yoken1952.50.241
   Jones RN, 1999, DIAGN MICR INFEC DIS, V35, P55, DOI 10.1016/S0732-8893(98)00158-8
   Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028
   Karlowsky JA, 2003, CLIN INFECT DIS, V36, P183, DOI 10.1086/345754
   Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002
   Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265
   *NCCLS, 2000M2A7 NCCLS
   Perrin M, 1999, J HOSP INFECT, V41, P273, DOI 10.1053/jhin.1998.0521
   Sader H S, 2001, Braz J Infect Dis, V5, P200
   Sahm DF, 2001, ANTIMICROB AGENTS CH, V45, P1402, DOI 10.1128/AAC.45.5.1402-1406.2001
   Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427
   Zhanel GG, 2000, ANTIMICROB AGENTS CH, V44, P1089, DOI 10.1128/AAC.44.4.1089-1092.2000
NR 22
TC 11
Z9 11
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1120-009X
EI 1973-9478
J9 J CHEMOTHERAPY
JI J. Chemother.
PD JUN
PY 2006
VL 18
IS 3
BP 255
EP 260
DI 10.1179/joc.2006.18.3.255
PG 6
WC Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy
SC Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy
GA 064SO
UT WOS:000239109600003
PM 17129835
DA 2020-12-09
ER

PT J
AU de Siqueira, IC
   Dias, J
   Ruf, H
   Ramos, EAG
   Maciel, EAP
   Rolim, A
   Jabur, L
   Vasconcelos, L
   Silvany, C
AF de Siqueira, IC
   Dias, J
   Ruf, H
   Ramos, EAG
   Maciel, EAP
   Rolim, A
   Jabur, L
   Vasconcelos, L
   Silvany, C
TI Chromobacterium violaceum in siblings, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID 1ST CASE-REPORT; FATAL SEPTICEMIA; INFECTIONS; DISEASE; SEPSIS
AB Chromobacterium violaceum, a saprophyte bacterium found commonly in soil and water in tropical and subtropical climates, is a rare cause of severe, often fatal, human disease. We report 1 confirmed and 2 suspected cases of C. violaceum septicemia, with 2 fatalities, in siblings after recreational exposure in northeastern Brazil.
C1 Obras Sociais Irma Dulce, Salvador, BA, Brazil.
   Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   Hlth Secretariat State Bahia, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Isadora Cristina Siqueira, Ctr Pesquisas Goncalo Moniz Fiocruz, Rua Waldemar Falcao,121 Brotas, BR-40295001 Salvador, BA, Brazil.
EM isiqueira@cpqgm.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
CR Chattopadhyay A, 2002, J PEDIATR SURG, V37, P108, DOI 10.1053/jpsu.2002.29439
   de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100
   KAUFMAN SC, 1986, J CLIN MICROBIOL, V23, P956, DOI 10.1128/JCM.23.5.956-958.1986
   MACHER AM, 1982, ANN INTERN MED, V97, P51, DOI 10.7326/0003-4819-97-1-51
   MAMLOK RJ, 1987, J PEDIATR-US, V111, P852, DOI 10.1016/S0022-3476(87)80203-2
   Martinez Roberto, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P111, DOI 10.1590/S0036-46652000000200008
   Moore CC, 2001, CLIN INFECT DIS, V32, pE107, DOI 10.1086/319356
   PETRILLO VF, 1984, J INFECTION, V9, P167, DOI 10.1016/S0163-4453(84)91234-9
   PONTE R, 1992, PEDIATR INFECT DIS J, V11, P583, DOI 10.1097/00006454-199207000-00013
   Shao PL, 2002, PEDIATR INFECT DIS J, V21, P707, DOI 10.1097/00006454-200207000-00022
   SIMO F, 1984, PEDIATR INFECT DIS J, V3, P561, DOI 10.1097/00006454-198411000-00017
   SNEATH PHA, 1953, LANCET, V265, P276
   STEINBERG JP, 2005, PRINCIPLES PRACTICE, P2751
   TI TY, 1993, CLIN INFECT DIS, V17, P505, DOI 10.1093/clinids/17.3.505
   White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0
NR 15
TC 17
Z9 23
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2005
VL 11
IS 9
BP 1443
EP 1445
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 960LG
UT WOS:000231591400019
PM 16229777
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Matsunaga, J
   Barocchi, MA
   Croda, J
   Young, TA
   Sanchez, Y
   Siqueira, I
   Bolin, CA
   Reis, MG
   Riley, LW
   Haake, DA
   Albert, KI
AF Matsunaga, J
   Barocchi, MA
   Croda, J
   Young, TA
   Sanchez, Y
   Siqueira, I
   Bolin, CA
   Reis, MG
   Riley, LW
   Haake, DA
   Albert, KI
TI Pathogenic Leptospira species express surface-exposed proteins belonging
   to the bacterial immunoglobulin superfamily
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID INTERROGANS SEROVAR COPENHAGENI; MESSENGER-RNA STABILITY; OUTER-MEMBRANE
   PROTEIN; MAMMALIAN INFECTION; MOLECULAR ANALYSIS; SEQUENCE-ANALYSIS;
   BINDING PROTEIN; CELLS; LIPOPROTEIN; CLONING
AB Proteins with bacterial immunoglobulin-like (Big) domains, such as the Yersinia pseudotuberculosis invasin and Escherichia coli intimin, are surface-expressed proteins that mediate host mammalian cell invasion or attachment. Here, we report the identification and characterization of a new family of Big domain proteins, referred to as Lig (leptospiral Ig-like) proteins, in pathogenic Leptospira. Screening of L. interrogans and L. kirschneri expression libraries with sera from leptospirosis patients identified 13 lambda phage clones that encode tandem repeats of the 90 amino acid Big domain. Two fig genes, designated ligA and ligB, and one pseudogene, ligC, were identified. The ligA and ligB genes encode amino-terminal lipoprotein signal peptides followed by 10 or 11 Big domain repeats and, in the case of ligB, a unique carboxy-terminal non-repeat domain. The organization of ligC is similar to that of ligB but contains mutations that disrupt the reading frame. The fig sequences are present in pathogenic but not saprophytic Leptospira species. LigA and LigB are expressed by a variety of virulent leptospiral strains. Loss of Lig protein and RNA transcript expression is correlated with the observed loss of virulence during culture attenuation of pathogenic strains. High-pressure freeze substitution followed by immunocytochemical electron microscopy confirmed that the Lig proteins were localized to the bacterial surface. Immunoblot studies with patient sera found that the Lig proteins are a major antigen recognized during the acute host infection. These observations demonstrate that the Lig proteins are a newly identified surface protein of pathogenic Leptospira, which by analogy to other bacterial immunoglobulin superfamily virulence factors, may play a role in host cell attachment and invasion during leptospiral pathogenesis.
C1 Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA.
   Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Immun, Berkeley, CA 94720 USA.
   Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA.
   Cornell Univ, Weill Med Coll, Div Internal Med & Infect Dis, New York, NY USA.
RP Haake, DA (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
EM dhaake@ucla.edu
RI Ko, Albert Icksang/P-2343-2015; de Siqueira, Isadora
   Cristina/R-9953-2016; Reis, Mitermayer/AAO-9742-2020; Croda,
   Julio/I-5172-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Reis, Mitermayer/0000-0002-3051-9060;
   Croda, Julio/0000-0002-6665-6825
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI034431, K08AI001605, R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431, R29AI034431, K08AI001605,
   R01AI034431, R29AI034431, R29AI034431, K08AI001605, R29AI034431,
   R01AI034431, R29AI034431, R01AI034431, R01AI034431, R21AI034431,
   R01AI034431, R01AI034431] Funding Source: NIH RePORTER; FIC NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW-00919, D43 TW000919, TW-00905, D43 TW000905] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI-34431, R21 AI034431,
   AI-01605, R01 AI034431, R29 AI034431] Funding Source: Medline
CR AREAN VM, 1962, AM J PATHOL, V40, P393
   BAILEY TL, 1994, ISMB, V2, P28
   BALLARD SA, 1986, J MED MICROBIOL, V21, P59, DOI 10.1099/00222615-21-1-59
   Ballard SA, 1998, GENE, V216, P21, DOI 10.1016/S0378-1119(98)00329-1
   BALLARD SA, 1993, MOL MICROBIOL, V8, P739, DOI 10.1111/j.1365-2958.1993.tb01617.x
   Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999
   Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276
   CASE CC, 1990, EMBO J, V9, P1259, DOI 10.1002/j.1460-2075.1990.tb08234.x
   CHANG SL, 1948, J INFECT DIS, V82, P256, DOI 10.1093/infdis/82.3.256
   de la Pena-Moctezuma A, 2001, FEMS IMMUNOL MED MIC, V31, P73, DOI 10.1111/j.1574-695X.2001.tb01589.x
   Dersch P, 2000, INFECT IMMUN, V68, P2930, DOI 10.1128/IAI.68.5.2930-2938.2000
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Faine S, 1982, GUIDELINES CONTROL L
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   GREENBERG EP, 1977, J BACTERIOL, V132, P356, DOI 10.1128/JB.132.1.356-358.1977
   GRUBER A, 1995, BIOTECHNIQUES, V19, P28
   Grunberg-Manago M, 1999, ANNU REV GENET, V33, P193, DOI 10.1146/annurev.genet.33.1.193
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002
   HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991
   Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291
   HELLSTROM JS, 1978, RES VET SCI, V25, P29, DOI 10.1016/S0034-5288(18)33003-0
   ITO T, 1987, VET MICROBIOL, V15, P89, DOI 10.1016/0378-1135(87)90133-7
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   JOST BH, 1989, J MED MICROBIOL, V29, P115, DOI 10.1099/00222615-29-2-115
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   MARSHALL RB, 1976, J MED MICROBIOL, V9, P149, DOI 10.1099/00222615-9-2-149
   Matsunaga J, 2002, INFECT IMMUN, V70, P323, DOI 10.1128/IAI.70.1.323-334.2002
   Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1016/S0378-1097(00)00044-6
   Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997
   Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001
   NILSSON G, 1987, P NATL ACAD SCI USA, V84, P4890, DOI 10.1073/pnas.84.14.4890
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851
   SEGERS RPAM, 1992, INFECT IMMUN, V60, P1707, DOI 10.1128/IAI.60.4.1707-1710.1992
   Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   THOMAS DD, 1990, INFECT IMMUN, V58, P581, DOI 10.1128/IAI.58.3.581-585.1990
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   TROWBRIDGE AA, 1981, AM J CLIN PATHOL, V76, P493
   TRUEBA GA, 1992, J BACTERIOL, V174, P4761, DOI 10.1128/JB.174.14.4761-4768.1992
   TSUCHIMOTO M, 1984, ZBL BAKT-INT J MED M, V258, P268, DOI 10.1016/S0176-6724(84)80044-9
   VINH T, 1984, J MED MICROBIOL, V18, P73, DOI 10.1099/00222615-18-1-73
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618
   YURI K, 1993, INFECT IMMUN, V61, P2270, DOI 10.1128/IAI.61.5.2270-2272.1993
   ZUERNER RL, 1991, MICROB PATHOGENESIS, V10, P311, DOI 10.1016/0882-4010(91)90014-2
NR 56
TC 184
Z9 190
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD AUG
PY 2003
VL 49
IS 4
BP 929
EP 945
DI 10.1046/j.1365-2958.2003.03619.x
PG 17
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 714WJ
UT WOS:000184936200007
PM 12890019
OA Green Accepted, Green Published, Bronze
DA 2020-12-09
ER

PT J
AU Magalhaes-Santos, IF
   Lemaire, DC
   Andrade, AS
   Queiroz, AC
   Carvalho, OM
   Carmo, TMA
   Siqueira, IC
   Andrade, DM
   Rego, MF
   Guedes, APT
   Reis, MG
AF Magalhaes-Santos, IF
   Lemaire, DC
   Andrade, AS
   Queiroz, AC
   Carvalho, OM
   Carmo, TMA
   Siqueira, IC
   Andrade, DM
   Rego, MF
   Guedes, APT
   Reis, MG
TI Antibodies to Schistosoma mansoni in human cerebrospinal fluid
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; MYELORADICULOPATHY; INVOLVEMENT;
   HAEMATOBIUM; DIAGNOSIS
AB Cerebrospinal fluid (CSF) and serum samples from patients suspected of having neuroschistosomiasis (NS) were evaluated by an enzyme-linked immunosorbent assay. Monoclonal antibodies of various immunoglobulin isotypes (IgM, IgA, IgE, total IgG, IgG1, IgG2, IgG3, and IgG4) were used to detect antibodies against Schistosoma mansoni soluble egg antigen (SEA) and soluble worm adult preparation (SWAP). Of the 83 CSF samples tested, 55% were reactive to SEA (26% were reactive only to SEA and 29% to both SEA and SWAP), 34% were reactive to SWAP (5% only to SWAP and 29% to both SEA and SWAP), and 40% were not reactive with any antigen. Cases that tested positive for SWAP in CSF and negative in serum were not found. Samples with high specific IgG antibody titers were selected for immunoglobulin isotype profiling. In the CSF samples, the antibodies against SEA and SWAP were mainly IgM, IgG1, and IgG4, although other immunoglobulins were also detected. Interestingly, nine patients had high levels of IgG1 only in the CSF. These results suggest that there is local synthesis of IgG1, and that this isotype could be an important immunologic marker in the diagnosis of NS.
C1 Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Oswaldo Cruz Fdn, BR-40295001 Salvador, BA, Brazil.
   Univ Fed Bahia, Salvador, BA, Brazil.
   Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   Jose Silveira Fdn, Salvador, BA, Brazil.
RP Reis, MG (corresponding author), Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Oswaldo Cruz Fdn, Rua Waldemar Falcao,121 Brotas, BR-40295001 Salvador, BA, Brazil.
EM miter@cpqgm.fiocruz.br
RI Reis, Mitermayer/AAO-9742-2020; de Siqueira, Isadora
   Cristina/R-9953-2016
OI Reis, Mitermayer/0000-0002-3051-9060; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [5U01-AI-16305-17] Funding Source: Medline;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI016305, U01AI016305, U01AI016305, U01AI016305, U01AI016305,
   U01AI016305, U01AI016305, U01AI016305, U01AI016305, U01AI016305,
   U01AI016305, U01AI016305, U01AI016305, U01AI016305, U01AI016305,
   U01AI016305, U01AI016305, U01AI016305, U01AI016305, U01AI016305,
   U01AI016305, U01AI016305, U01AI016305, U01AI016305, U01AI016305,
   U01AI016305, U01AI016305, U01AI016305, U01AI016305, U01AI016305,
   U01AI016305, U01AI016305, U01AI016305, U01AI016305, U01AI016305,
   U01AI016305, U01AI016305, U01AI016305, U01AI016305, U01AI016305] Funding
   Source: NIH RePORTER
CR ANDRADE AS, 1991, ARQ NEURO-PSIQUIAT, V49, P80
   ANDRADE NA, 1986, ARQ NEURO-PSIQUIAT, V44, P275
   CANELAS H M, 1951, Arq Neuropsiquiatr, V9, P48
   Ferrari TCA, 1999, T ROY SOC TROP MED H, V93, P558, DOI 10.1016/S0035-9203(99)90381-4
   FERRARI TCA, 1995, T ROY SOC TROP MED H, V89, P496, DOI 10.1016/0035-9203(95)90083-7
   FERRARI TCA, 1993, ANN TROP MED PARASIT, V87, P295, DOI 10.1080/00034983.1993.11812769
   HARN DA, 1984, J EXP MED, V159, P1371, DOI 10.1084/jem.159.5.1371
   HOUPIS J, 1984, JAMA-J AM MED ASSOC, V252, P1119
   HOUPIS J, 1984, JAMA-J AM MED ASSOC, V252, P1123
   HOUPIS J, 1984, JAMA-J AM MED ASSOC, V252, P1116
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Livramento J A, 1985, Arq Neuropsiquiatr, V43, P372
   Mackenzie IRA, 1998, J NEUROSURG, V89, P1052, DOI 10.3171/jns.1998.89.6.1052
   MOTT KE, 1982, B WORLD HEALTH ORGAN, V60, P729
   PAMMENTER MD, 1991, AM J TROP MED HYG, V44, P329, DOI 10.4269/ajtmh.1991.44.329
   PELLEGRINO AJP, 1988, ARQ NEURO-PSIQUIAT, V46, P49
   PITTELLA JEH, 1989, AM J TROP MED HYG, V41, P548, DOI 10.4269/ajtmh.1989.41.548
   PITTELLA JEH, 1991, J TROP MED HYG, V94, P15
   PITTELLA JEH, 1981, BRAIN, V104, P621, DOI 10.1093/brain/104.3.621
   POLLNER JH, 1994, CLIN INFECT DIS, V18, P354, DOI 10.1093/clinids/18.3.354
   QUEIROZ AC, 1984, ACTA MEDICA PORT, V5, P219
   Salum P N, 1981, Arq Neuropsiquiatr, V39, P289
   SCRIMGEOUR EM, 1985, BRAIN, V108, P1023, DOI 10.1093/brain/108.4.1023
   SILBERGLEIT R, 1992, AM J ROENTGENOL, V158, P1351, DOI 10.2214/ajr.158.6.1590139
   World Health Organization, 1996, STAT WORLDS VACC IMM, P1
NR 25
TC 23
Z9 24
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAR
PY 2003
VL 68
IS 3
BP 294
EP 298
DI 10.4269/ajtmh.2003.68.294
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 657QL
UT WOS:000181677800009
PM 12685632
OA Green Published, Bronze
DA 2020-12-09
ER

PT J
AU Maciel, E
   Siqueira, I
   Queiroz, AC
   Melo, A
AF Maciel, E
   Siqueira, I
   Queiroz, AC
   Melo, A
TI Toxoplasma gondii myelitis in a patient with adult T-cell
   leukemia-lymphoma
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE HTLV-I; immunosupression; Toxoplasma gondii; myelitis
ID MYELOPATHY; LEUKEMIA/LYMPHOMA
AB Adult T cell leukemia-lymphoma (ATL) caused by HTLV-I may be associated with severe immunosupression and several opportunistic infections. Toxoplasmic encephalitis is a common central nervous system opportunistic infection in severley immunosuppressed patients, however spinal cord involvement by this parasite is rare. In this paper, we report a case of toxoplasmic myelitis in a patient with ATL.
C1 Univ Fed Bahia, Fac Med, Dept Neuropsiquiatria, Div Neuroinfectol & Epidemiol, BR-41170290 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med, Dept Anat Patol, BR-41170290 Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Melo,
   Ailton/0000-0001-7457-0573
CR BRYAN JM, 1996, CLIN INFECT DIS, V23, P138
   Freitas V, 1997, ARQ NEURO-PSIQUIAT, V55, P325, DOI 10.1590/S0004-282X1997000200024
   Greenberg MK, 1998, NEUROLOGY, V50, P21
   KAWAI H, 1989, NEUROLOGY, V39, P1129, DOI 10.1212/WNL.39.8.1129
   Manns A, 1999, LANCET, V353, P1951, DOI 10.1016/S0140-6736(98)09460-4
   NAG S, 1989, CAN J NEUROL SCI, V16, P422, DOI 10.1017/S0317167100029504
   RHEW DC, 1995, CLIN INFECT DIS, V21, P1014, DOI 10.1093/clinids/21.4.1014
   SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x
   Vyas R, 1996, CLIN INFECT DIS, V23, P1061, DOI 10.1093/clinids/23.5.1061
   WHITE JD, 1995, CANCER, V75, P1598, DOI 10.1002/1097-0142(19950401)75:7<1598::AID-CNCR2820750708>3.0.CO;2-7
NR 10
TC 10
Z9 10
U1 0
U2 3
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2000
VL 58
IS 4
BP 1107
EP 1109
DI 10.1590/S0004-282X2000000600019
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 379ZC
UT WOS:000165672200019
PM 11105079
OA DOAJ Gold
DA 2020-12-09
ER

EF